<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://brain.oxfordjournals.org">
<title>Brain - Advance Access</title>
<link>http://brain.oxfordjournals.org</link>
<description>Brain - RSS feed of articles</description>
<prism:eIssn>1460-2156</prism:eIssn>
<prism:publicationName>Brain</prism:publicationName>
<prism:issn>0006-8950</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp178v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp162v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp163v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp177v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp170v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp169v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp165v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp152v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp151v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp150v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp160v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp156v2?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp159v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp148v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp144v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp154v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp147v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp158v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp157v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp155v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp153v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp146v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp145v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp142v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp138v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp161v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp137v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp132v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp126v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp125v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp143v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp124v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp123v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp063v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp100v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp117v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp105v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp089v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp071v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp111v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp053v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp098v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp095v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp094v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp091v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp086v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp077v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp088v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp083v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp060v2?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp079v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp027v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp040v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp038v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp064v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp022v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp021v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awp043v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awn181v1?rss=1" />
  <rdf:li rdf:resource="http://brain.oxfordjournals.org/cgi/content/short/awh430v4?rss=1" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp178v1?rss=1">
<title><![CDATA[Selective changes in GABAA receptor subtypes in white matter neurons of patients with focal epilepsy]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp178v1?rss=1</link>
<description><![CDATA[
<p>Mapping the distribution of GABA<SUB>A</SUB> receptor subtypes represents a promising approach to characterize alterations in cortical circuitry associated with neurological disorders. We previously reported subtype-selective changes in GABA<SUB>A</SUB> receptor expression in the grey matter of patients with focal epilepsy. In the present follow-up study, we focused on the subcortical white matter in the same tissue specimens obtained at surgery from 9 patients with temporal lobe epilepsy (TLE) and hippocampal sclerosis, 12 patients with TLE associated with neocortical lesions and 5 patients with frontal lobe epilepsy; post-mortem tissue from 4 subjects served as controls. The subunit composition and distribution of three major GABA<SUB>A</SUB> receptor subtypes were determined immunohistochemically with subunit-specific antibodies. In all cases, a majority of neurons in the white matter was distinctly labelled, allowing detailed visualization of their dendritic arborization and revealing a differential, cell type-specific expression pattern of -subunit variants. In controls, 1-subunit staining was most prominent, displaying a gradient that decreased with depth, in parallel with the density of NeuN-positive cells. Subsets of pyramidal cells were 3-subunit-positive, and 2-subunit-labelled neurons were rare. In 19 of the 26 patients with focal epilepsy, no changes were detected as compared with controls. In five patients with TLE, striking changes in the dendritic arborization of a subset of white matter neurons were seen with the 1-subunit antibody. In two further patients with TLE, we observed a disorganized dendritic network immuno-positive for the 1-subunit, cell clusters selectively expressing the 2-subunit and small neuronal aggregates that expressed all subunits and appeared to connect to neighbouring white matter neurons. All seven patients with anomalies in the white matter had a selective reduction in 3-containing GABA<SUB>A</SUB> receptors in the superficial layers of the grey matter. These results demonstrate a distinct organization of GABA<SUB>A</SUB> receptors in human white matter neurons, consistent with an inhibitory network that is likely to be integrated functionally with the overlying grey matter. The altered dendritic morphology and changes in GABA<SUB>A</SUB> receptor expression in the white matter of a subset of patients with focal epilepsy are suggestive for a rewiring of neuronal circuits.</p>
]]></description>
<dc:creator><![CDATA[Loup, F., Picard, F., Yonekawa, Y., Wieser, H.-G., Fritschy, J.-M.]]></dc:creator>
<dc:date>2009-07-02</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp178</dc:identifier>
<dc:title><![CDATA[Selective changes in GABAA receptor subtypes in white matter neurons of patients with focal epilepsy]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-02</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp162v1?rss=1">
<title><![CDATA[Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp162v1?rss=1</link>
<description><![CDATA[
<p>Recombinant tissue-type plasminogen activator (tPA) is the fibrinolytic drug of choice to treat stroke patients. However, a growing body of evidence indicates that besides its beneficial thrombolytic role, tPA can also have a deleterious effect on the ischaemic brain. Although ageing influences stroke incidence, complications and outcome, age-dependent relationships between endogenous tPA and stroke injuries have not been investigated yet. Here, we report that ageing is associated with a selective lowering of brain tPA expression in the murine brain. Moreover, our results show that albumin D site-binding protein (DBP) as a key age-associated regulator of the neuronal transcription of tPA. Additionally, inhibition of DBP-mediated tPA expression confers <I>in vitro</I> neuroprotection. Accordingly, reduced levels of tPA in old mice are associated with smaller excitotoxic/ischaemic injuries and protection of the permeability of the neurovascular unit during cerebral ischaemia. Likewise, we provide neuroradiological evidence indicating the existence of an inverse relationship between age and the volume of the ischaemic lesion in patients with acute ischaemic stroke. Together, these results indicate that the relationship among DBP, tPA and ageing play an important role in the outcome of cerebral ischaemia.</p>
]]></description>
<dc:creator><![CDATA[Roussel, B. D., Macrez, R., Jullienne, A., Agin, V., Maubert, E., Dauphinot, L., Potier, M.-C., Plawinski, L., Castel, H., Hommet, Y., Munuera, J., Montaner, J., Yepes, M., Ali, C., Vivien, D.]]></dc:creator>
<dc:date>2009-07-02</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp162</dc:identifier>
<dc:title><![CDATA[Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-02</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp163v1?rss=1">
<title><![CDATA[TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp163v1?rss=1</link>
<description><![CDATA[
<p>We provide evidence that TWIK-related acid-sensitive potassium channel 1 (TASK1), a member of the family of two-pore domain potassium channels relevant for setting the resting membrane potential and balancing neuronal excitability that is expressed on T cells and neurons, is a key modulator of T cell immunity and neurodegeneration in autoimmune central nervous system inflammation. After induction of experimental autoimmune encephalomyelitis, an experimental model mimicking multiple sclerosis, TASK1<sup>&ndash;/&ndash;</sup> mice showed a significantly reduced clinical severity and markedly reduced axonal degeneration compared with wild-type controls. T cells from TASK1<sup>&ndash;/&ndash;</sup> mice displayed impaired T cell proliferation and cytokine production, while the immune repertoire is otherwise normal. In addition to these effects on systemic T cell responses, TASK1 exhibits an independent neuroprotective effect which was demonstrated using both a model of acutely prepared brain slices cocultured with activated T cells as well as <I>in vitro</I> cultivation experiments with isolated optic nerves. Anandamide, an endogenous cannabinoid and inhibitor of TASK channels, reduced outward currents and inhibited effector functions of T cells (IFN- production and proliferation); an effect completely abrogated in TASK1<sup>&ndash;/&ndash;</sup> mice. Accordingly, preventive blockade of TASK1 significantly ameliorated experimental autoimmune encephalomyelitis after immunization. Therapeutic application of anandamide significantly reduced disease severity and was capable of lowering progressive loss of brain parenchymal volume as assessed by magnetic resonance imaging. These data support the identification and characterization of TASK1 as potential molecular target for the therapy of inflammatory and degenerative central nervous system disorders.</p>
]]></description>
<dc:creator><![CDATA[Bittner, S., Meuth, S. G., Gobel, K., Melzer, N., Herrmann, A. M., Simon, O. J., Weishaupt, A., Budde, T., Bayliss, D. A., Bendszus, M., Wiendl, H.]]></dc:creator>
<dc:date>2009-07-01</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp163</dc:identifier>
<dc:title><![CDATA[TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp177v1?rss=1">
<title><![CDATA[The cortical innate immune response increases local neuronal excitability leading to seizures]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp177v1?rss=1</link>
<description><![CDATA[
<p>Brain glial cells, five times more prevalent than neurons, have recently received attention for their potential involvement in epileptic seizures. Microglia and astrocytes, associated with inflammatory innate immune responses, are responsible for surveillance of brain damage that frequently results in seizures. Thus, an intriguing suggestion has been put forward that seizures may be facilitated and perhaps triggered by brain immune responses. Indeed, recent evidence strongly implicates innate immune responses in lowering seizure threshold in experimental models of epilepsy, yet, there is no proof that they can play an independent role in initiating seizures <I>in vivo</I>. Here, we show that cortical innate immune responses alone produce profound increases of brain excitability resulting in focal seizures. We found that cortical application of lipopolysaccharide, binding to toll-like receptor 4 (TLR4), triples evoked field potential amplitudes and produces focal epileptiform discharges. These effects are prevented by pre-application of interleukin-1 receptor antagonist. Our results demonstrate how the innate immune response may participate in acute seizures, increasing neuronal excitability through interleukin-1 release in response to TLR4 detection of the danger signals associated with infections of the central nervous system and with brain injury. These results suggest an important role of innate immunity in epileptogenesis and focus on glial inhibition, through pharmacological blockade of TLR4 and the pro-inflammatory mediators released by activated glia, in the study and treatment of seizure disorders in humans.</p>
]]></description>
<dc:creator><![CDATA[Rodgers, K. M., Hutchinson, M. R., Northcutt, A., Maier, S. F., Watkins, L. R., Barth, D. S.]]></dc:creator>
<dc:date>2009-06-30</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp177</dc:identifier>
<dc:title><![CDATA[The cortical innate immune response increases local neuronal excitability leading to seizures]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-30</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp170v1?rss=1">
<title><![CDATA[At-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp170v1?rss=1</link>
<description><![CDATA[
<p>Treatment with dopamine receptor agonists has been associated with impulse control disorders and pathological gambling (PG) secondary to medication in previously unaffected patients with Parkinson's disease or restless legs syndrome (RLS). In a within-subjects design, we investigated the underlying neurobiology in RLS patients using functional magnetic resonance imaging. We scanned 12 female RLS patients without a history of PG. All patients were scanned twice: once whilst taking their regular medication with low dose dopamine receptor agonists and once after a washout phase interval. They performed an established gambling game task involving expectation and receipt or omission of monetary rewards at different levels of probabilities. Upon expectation of rewards, reliable ventral striatal activation was detected only when patients were on, but not when patients were off medication. Upon receipt or omission of rewards, the observed ventral striatal signal under medication differed markedly from its predicted pattern which by contrast was apparent when patients were off medication. Orbitofrontal activation was not affected by medication. Chronic dopamine receptor agonist medication changed the neural signalling of reward expectation predisposing the dopaminergic reward system to mediate an increased appetitive drive. Even without manifest PG, chronic medication with dopamine receptor agonists led to markedly changed neural processing of negative consequences probably mediating dysfunctional learning of contingencies. Intact orbitofrontal functioning, potentially moderating impulse control, may explain why none of the patients actually developed PG. Our results support the notion of a general medication effect in patients under dopamine receptor agonists in terms of a sensitization towards impulse control disorders.</p>
]]></description>
<dc:creator><![CDATA[Abler, B., Hahlbrock, R., Unrath, A., Gron, G., Kassubek, J.]]></dc:creator>
<dc:date>2009-06-30</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp170</dc:identifier>
<dc:title><![CDATA[At-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-30</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp169v1?rss=1">
<title><![CDATA[Longitudinal study of intraneural perineurioma--a benign, focal hypertrophic neuropathy of youth]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp169v1?rss=1</link>
<description><![CDATA[
<p>The natural history of intraneural perineurioma has been inadequately studied. The aim of this study was to characterize the clinical presentation, electrophysiologic and imaging features and outcome of intraneural perineurioma. We ask if intraneural perineurioma is a pure motor syndrome that remains confined to one nerve and should be treated by surgical resection. We examined the nerve biopsies of cases labelled perineurioma and selected those with diagnostic features. Thirty-two patients were identified; 16 children and 16 adults; 16 males and 16 females. Median age of onset of neurological symptoms was 14 years (range 0.5&ndash;55 years) and median age at evaluation was 17 years (range 2&ndash;56 years). All patients had motor deficits; however, mild sensory symptoms or signs were experienced by 27 patients; &lsquo;prickling&rsquo; or &lsquo;asleep numbness&rsquo; in 20, mild pain in 13 and sensory loss in 23. The sciatic nerve or its branches was most commonly affected in 15, followed by brachial plexus, radial nerve and ulnar nerve (four each). Magnetic resonance imaging demonstrated nerve enlargement (29/32), T<SUB>1</SUB> isointensity (27/32), T<SUB>2</SUB> hyperintensity (25/32) and contrast enhancement (20/20). Diagnoses were made based on targeted biopsy of the focal nerve enlargement identified by imaging. Neurological impairment was of a moderate severity (median Neuropathy Impairment Score was 12 points, range 2&ndash;49 points). All patients had focal involvement with 27 involving one nerve and five involving a plexus (one bilateral). Long-term follow-up was possible by telephone interview for 23 patients (median 36 months, range 2&ndash;177 months). Twelve patients also had follow-up neurologic evaluation (median 45 months, range 10&ndash;247 months). The median Neuropathy Impairment Score had changed from 12.6 to 15.4 points (<I>P</I> = 0.19). In all cases, the distribution of neurologic findings remained unchanged. Median Dyck Disability Score was 3 (range 2&ndash;5) indicating a mild impairment without interfering with activities of daily living. Ten patients judged their symptoms unchanged, nine slightly worse and four slightly better. We conclude intraneural perineurioma is a benign hypertrophic (non onion bulb) peripheral nerve tumour that presents insidiously in young people and is motor predominant with mild sensory involvement. It is most often a mononeuropathy, but a plexopathy can occur. Diagnosis of this condition requires clinical suspicion, imaging, targeted fascicular biopsy of the lesion and expertise of nerve pathologists. As these tumours are static or slowly progressive, remain confined to their original distribution and have low morbidity, they probably should not be resected routinely. Because intensive evaluation is needed for diagnosis, intraneural perineurioma is probably under-recognized.</p>
]]></description>
<dc:creator><![CDATA[Mauermann, M. L., Amrami, K. K., Kuntz, N. L., Spinner, R. J., Dyck, P. J., Bosch, E. P., Engelstad, J., Felmlee, J. P., Dyck, P. J. B.]]></dc:creator>
<dc:date>2009-06-30</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp169</dc:identifier>
<dc:title><![CDATA[Longitudinal study of intraneural perineurioma--a benign, focal hypertrophic neuropathy of youth]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-30</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp165v1?rss=1">
<title><![CDATA[Anatomical correlates of ocular motor deficits in cerebellar lesions]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp165v1?rss=1</link>
<description><![CDATA[
<p>Humans are able to stabilize the images of moving targets on the retina by means of smooth pursuit eye movements. After the pontine level, all smooth pursuit pathways pass through the cerebellum. Previous animal studies gave evidence that two specific lesion sites within the cerebellum cause smooth pursuit disorders: those of the flocculus/paraflocculus and the vermis including lobule VI, VII, the uvula and the deep cerebellar nuclei. To date, there have been only a few lesion studies in patients with smooth pursuit disorders that do not allow direct comparison with a control group. In the present study, new lesion mapping techniques determined which cerebellar structures were involved in patients with deficits of smooth pursuit eye movements, slow phase of optokinetic nystagmus (OKN) and fixation suppression of vestibulo-ocular reflex, i.e. in eye movements that are considered to belong to the smooth pursuit system. The aim was to elucidate whether there is an anatomical and clinical link between these different eye movement disorders. Seventeen patients with acute, mainly unilateral cerebellar infarctions and an intact gain of the smooth pursuit system were compared with 11 patients with cerebellar lesions and deficient gain of sinusoidal smooth pursuit eye movements by means of lesion-mapping imaging. In addition, lesion analyses were conducted in subgroups with impaired fixation suppression of vestibulo-ocular reflex and deficient gain of the slow phase of the OKN. The uvula and partly the vermal pyramid were found to be the structures commonly damaged in patients with deficient gain of the horizontal sinusoidal smooth pursuit eye movement, of the slow phase of the OKN and impaired fixation suppression of vestibulo-ocular reflex; and were less involved in patients with intact smooth pursuit system. The present data give evidence for an anatomical link between sinusoidal smooth pursuit eye movements, fixation suppression of vestibulo-ocular reflex and the slow phases of OKN implying that the uvula and the vermal pyramid are important structures for generating slow phases within the smooth pursuit network in humans.</p>
]]></description>
<dc:creator><![CDATA[Baier, B., Stoeter, P., Dieterich, M.]]></dc:creator>
<dc:date>2009-06-30</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp165</dc:identifier>
<dc:title><![CDATA[Anatomical correlates of ocular motor deficits in cerebellar lesions]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-30</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp152v1?rss=1">
<title><![CDATA[Clinical manifestation and a new ISCU mutation in iron-sulphur cluster deficiency myopathy]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp152v1?rss=1</link>
<description><![CDATA[
<p>Myopathy with deficiency of succinate dehydrogenase and aconitase is a recessively inherited disorder characterized by childhood-onset early fatigue, dyspnoea and palpitations on trivial exercise. The disease is non-progressive, but life-threatening episodes of widespread weakness, severe metabolic acidosis and rhabdomyolysis may occur. The disease has so far only been identified in northern Sweden. The clinical, histochemical and biochemical phenotype is very homogenous and the patients are homozygous for a deep intronic IVS5 + 382G&gt;C splicing affecting mutation in <I>ISCU</I>, which encodes the differently spliced cytosolic and mitochondrial iron&ndash;sulphur cluster assembly protein IscU. Iron&ndash;sulphur cluster containing proteins are essential for iron homeostasis and respiratory chain function, with IscU being among the most conserved proteins in evolution. We identified a shared homozygous segment of only 405 000 base pair with the deep intronic mutation in eight patients with a phenotype consistent with the original description of the disease. Two other patients, two brothers, had an identical biochemical and histochemical phenotype which is probably pathognomonic for muscle iron&ndash;sulphur cluster deficiency, but they presented with a disease where the clinical phenotype was characterized by early onset of a slowly progressive severe muscle weakness, severe exercise intolerance and cardiomyopathy. The brothers were compound heterozygous for the deep intronic mutation and had a c.149 G&gt;A missense mutation in exon 3 changing a completely conserved glycine residue to a glutamate. The missense mutation was inherited from their mother who was of Finnish descent. The intronic mutation affects mRNA splicing and results in inclusion of pseudoexons in most transcripts in muscle. The pseudoexon inclusion results in a change in the reading frame and appearance of a premature stop codon. In western blot analysis of protein extracts from fibroblasts, there was no pronounced reduction of IscU in any of the patients, but the analysis revealed that the species corresponding to mitochondrial IscU migrates slower than a species present only in whole cells. In protein extracted from isolated skeletal muscle mitochondria the western blot analysis revealed a severe deficiency of IscU in the homozygous patients and appearance of a faint new fraction that could represent a truncated protein. There was only a slight reduction of mitochondrial IscU in the compound heterozygotes, despite their severe phenotype, indicating that the IscU expressed in these patients is non-functional.</p>
]]></description>
<dc:creator><![CDATA[Kollberg, G., Tulinius, M., Melberg, A., Darin, N., Andersen, O., Holmgren, D., Oldfors, A., Holme, E.]]></dc:creator>
<dc:date>2009-06-30</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp152</dc:identifier>
<dc:title><![CDATA[Clinical manifestation and a new ISCU mutation in iron-sulphur cluster deficiency myopathy]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-30</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp151v1?rss=1">
<title><![CDATA[Parkinson's disease, DBS and suicide: a role for serotonin?]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp151v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Voon, V., Krack, P., Lang, A. E., Lozano, A. M., Dujardin, K., Schupbach, M., Thobois, S., Tamma, F., Herzog, J., Samanta, J., Kubu, C., Rossignol, H., Poon, Y.-Y., Saint-Cyr, J. A., Ardouin, C., Moro, E.]]></dc:creator>
<dc:date>2009-06-24</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp151</dc:identifier>
<dc:title><![CDATA[Parkinson's disease, DBS and suicide: a role for serotonin?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-24</prism:publicationDate>
<prism:section>Letter to the Editor</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp150v1?rss=1">
<title><![CDATA[Parkinson's disease, DBS and suicide: a role for serotonin?]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp150v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Temel, Y., Tan, S., Visser-Vandewalle, V., Sharp, T.]]></dc:creator>
<dc:date>2009-06-24</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp150</dc:identifier>
<dc:title><![CDATA[Parkinson's disease, DBS and suicide: a role for serotonin?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-24</prism:publicationDate>
<prism:section>Letter to the Editor</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp160v1?rss=1">
<title><![CDATA[Ablation of adhesion molecule L1 in mice favours Schwann cell proliferation and functional recovery after peripheral nerve injury]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp160v1?rss=1</link>
<description><![CDATA[
<p>The adhesion molecule L1 is one of the few adhesion molecules known to be beneficial for repair processes in the adult central nervous system of vertebrates by promoting axonal growth and neuronal survival. In the peripheral nervous system, L1 is up-regulated by myelination-competent Schwann cells and regenerating axons after nerve damage but its functional role has remained unknown. Here we tested the hypothesis that L1 is, as in the central nervous system, beneficial for nerve regeneration in the peripheral nervous system by performing combined functional and histological analyses of adult L1-deficient mice (L1y/&ndash;) and wild-type (L1y/+) littermates. Contrary to our hypothesis, quantitative video-based motion analysis revealed better locomotor recovery in L1y/&ndash; than in L1y/+ mice at 4&ndash;12 weeks after transection and surgical repair of the femoral nerve. Motoneuron regeneration in L1y/&ndash; mice was also enhanced as indicated by attenuated post-traumatic loss of motoneurons, enhanced precision of motor reinnervation, larger cell bodies of regenerated motoneurons and diminished loss of inhibitory synaptic input to motoneurons. In search of mechanisms underlying the observed effects, we analysed peripheral nerves at short time-periods (3&ndash;14 days) after transection and found that Schwann cell proliferation is strongly augmented in L1y/&ndash; versus L1y/+ mice. L1-deficient Schwann cells showed increased proliferation than wild-type Schwann cells, both <I>in vivo</I> and <I>in vitro</I>. These findings suggest a novel role for L1 in nerve regeneration. We propose that L1 negatively regulates Schwann cell proliferation after nerve damage, which in turn restricts functional recovery by limiting the trophic support for regenerating motoneurons.</p>
]]></description>
<dc:creator><![CDATA[Guseva, D., Angelov, D. N., Irintchev, A., Schachner, M.]]></dc:creator>
<dc:date>2009-06-18</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp160</dc:identifier>
<dc:title><![CDATA[Ablation of adhesion molecule L1 in mice favours Schwann cell proliferation and functional recovery after peripheral nerve injury]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-18</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp156v2?rss=1">
<title><![CDATA[Temporal Discrimination Threshold: VBM evidence for an endophenotype in adult onset primary torsion dystonia]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp156v2?rss=1</link>
<description><![CDATA[
<p>Familial adult-onset primary torsion dystonia is an autosomal dominant disorder with markedly reduced penetrance. Most adult-onset primary torsion dystonia patients are sporadic cases. Disordered sensory processing is found in adult-onset primary torsion dystonia patients; if also present in their unaffected relatives this abnormality may indicate non-manifesting gene carriage. Temporal discrimination thresholds (TDTs) are abnormal in adult-onset primary torsion dystonia, but their utility as a possible endophenotype has not been examined. We examined 35 adult-onset primary torsion dystonia patients (17 familial, 18 sporadic), 42 unaffected first-degree relatives of both familial and sporadic adult-onset primary torsion dystonia patients, 32 unaffected second-degree relatives of familial adult-onset primary torsion dystonia (AOPTD) patients and 43 control subjects. TDT was measured using visual and tactile stimuli. In 33 unaffected relatives, voxel-based morphometry was used to compare putaminal volumes between relatives with abnormal and normal TDTs. The mean TDT in 26 control subjects under 50 years of age was 22.85 ms (SD 8.00; 95% CI: 19.62&ndash;26.09 ms). The mean TDT in 17 control subjects over 50 years was 30.87 ms (SD 5.48; 95% CI: 28.05&ndash;33.69 ms). The upper limit of normal, defined as control mean + 2.5 SD, was 42.86 ms in the under 50 years group and 44.58 ms in the over 50 years group. Thirty out of thirty-five (86%) AOPTD patients had abnormal TDTs with similar frequencies of abnormalities in sporadic and familial patients. Twenty-two out of forty-two (52%) unaffected first-degree relatives had abnormal TDTs with similar frequencies in relatives of sporadic and familial AOPTD patients. Abnormal TDTs were found in 16/32 (50%) of second-degree relatives. Voxel-based morphometry analysis comparing 13 unaffected relatives with abnormal TDTs and 20 with normal TDTs demonstrated a bilateral increase in putaminal grey matter in unaffected relatives with abnormal TDTs. The prevalence of abnormal TDTs in sporadic and familial AOPTD patients and their first-degree relatives follows the rules for a useful endophenotype. A structural correlate of abnormal TDTs in unaffected first-degree relatives was demonstrated using voxel-based morphometry. Voxel-based morphometry findings indicate that putaminal enlargement in AOPTD is a primary phenomenon. TDTs may be an effective tool in AOPTD research with particular relevance to genetic studies of the disorder.</p>
]]></description>
<dc:creator><![CDATA[Bradley, D., Whelan, R., Walsh, R., Reilly, R. B., Hutchinson, S., Molloy, F., Hutchinson, M.]]></dc:creator>
<dc:date>2009-06-18</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp156</dc:identifier>
<dc:title><![CDATA[Temporal Discrimination Threshold: VBM evidence for an endophenotype in adult onset primary torsion dystonia]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-18</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp159v1?rss=1">
<title><![CDATA[Speech experience shapes the speechreading network and subsequent deafness facilitates it]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp159v1?rss=1</link>
<description><![CDATA[
<p>Speechreading is a visual communicative skill for perceiving speech. In this study, we tested the effects of speech experience and deafness on the speechreading neural network in normal hearing controls and in two groups of deaf patients who became deaf either before (prelingual deafness) or after (postlingual deafness) auditory language acquisition. Magnetic signals from the cerebral cortex were recorded using a 306-channel magnetoencephalographic system. During magnetoencephalographic measurements, subjects were asked to perform a speechreading task from video clips of a female speaker either pronouncing syllables (speechreading condition) or showing closed-mouth movement. The sources of the evoked fields were modelled using equivalent current dipoles, the origins of which were fitted to the intracranial space based on magnetic resonance imaging findings. During the speechreading condition, the latency of auditory cortex activation was shorter in the postlingual deafness group than in the normal hearing control group. This parameter negatively correlated with speechreading scores measured clinically. Furthermore, as the duration of deafness increased, the latency of auditory cortex activation decreased exponentially. However, no such correlation was found in the prelingual deafness group which differed significantly from the two other groups in this respect. The latency of auditory cortex activation was significantly longer in the prelingual deafness group than in the two other groups. Thus, auditory experience may be crucial for the development of a normal neural network for speechreading. The pre-existing speechreading network in the postlingual deafness group is made more efficient by speeding up the neural response.</p>
]]></description>
<dc:creator><![CDATA[Suh, M.-W., Lee, H.-J., Sic Kim, J., Kee Jung, C., Oh, S.-H.]]></dc:creator>
<dc:date>2009-06-16</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp159</dc:identifier>
<dc:title><![CDATA[Speech experience shapes the speechreading network and subsequent deafness facilitates it]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-16</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp148v1?rss=1">
<title><![CDATA[Accuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp148v1?rss=1</link>
<description><![CDATA[
<p>Understanding how the hippocampus processes episodic memory information during neuropathological conditions is important for treatment and prevention applications. Previous data have shown that during chronic neuroinflammation the expression of the plasticity related behaviourally-induced immediate early gene <I>Arc</I> is altered within the CA3 and the dentate gyrus; both of these hippocampal regions show a pronounced increase in activated microglia. Low doses of memantine, a low to moderate affinity open channel uncompetitive <I>N</I>-Methyl-<scp>d</scp>-aspartate receptor antagonist, reduce neuroinflammation, return <I>Arc</I> expression to control levels and attenuate cognitive deficits induced by lipopolysaccharide. Here we investigate whether neuroinflammation affects the accuracy of information processing in the CA3 and CA1 hippocampal regions and if this is modified by memantine treatment. Using the immediate early gene-based brain-imaging method called cellular analysis of temporal activity by fluorescence <I>in situ</I> hybridization, it is possible to detect primary transcripts at the genomic alleles; this provides exceptional temporal and cellular resolution and facilitates the mapping of neuronal activity. Here, we use this method to compare the neuronal populations activated by two separate experiences in CA1 and CA3 and evaluate the accuracy of information processing during chronic neuroinflammation. Our results show that the CA3 pyramidal neuron activity is not stable between two exposures to the same environment context or two different contexts. CA1 networks, however, do not differ from control conditions. These data suggest that during chronic neuroinflammation, the CA3 networks show a disrupted ability to encode spatial information, and that CA1 neurons can work independently of CA3. Importantly, memantine treatment is able to partially normalize information processing in the hippocampus, suggesting that when given early during the development of the pathology memantine confers neuronal and cognitive protection while indirectly prevents pathological microglial activation.</p>
]]></description>
<dc:creator><![CDATA[Rosi, S., Ramirez-Amaya, V., Vazdarjanova, A., Esparza, E. E., Larkin, P. B., Fike, J. R., Wenk, G. L., Barnes, C. A.]]></dc:creator>
<dc:date>2009-06-16</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp148</dc:identifier>
<dc:title><![CDATA[Accuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-16</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp144v1?rss=1">
<title><![CDATA[CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp144v1?rss=1</link>
<description><![CDATA[
<p>The chemokine receptor CCR2 plays a vital role for the induction of autoimmunity in the central nervous system. However, it remains unclear how the pathogenic response is mediated by CCR2-bearing cells. By combining bone marrow chimerism with gene targeting we detected a mild disease-modulating role of CCR2 during experimental autoimmune encephalomyelitis, a model for central nervous system autoimmunity, on radio-resistant cells that was independent from targeted CCR2 expression on endothelia. Interestingly, absence of CCR2 on lymphocytes did not influence autoimmune demyelination. In contrast, engagement of CCR2 on accessory cells was required for experimental autoimmune encephalomyelitis induction. CCR2<sup>+</sup>Ly-6C<sup>hi</sup> monocytes were rapidly recruited to the inflamed central nervous system and were crucial for the effector phase of disease. Selective depletion of this specific monocyte subpopulation through engagement of CCR2 strongly reduced central nervous system autoimmunity. Collectively, these data indicate a disease-promoting role of CCR2<sup>+</sup>Ly-6C<sup>hi</sup> monocytes during autoimmune inflammation of the central nervous system.</p>
]]></description>
<dc:creator><![CDATA[Mildner, A., Mack, M., Schmidt, H., Bruck, W., Djukic, M., Zabel, M. D., Hille, A., Priller, J., Prinz, M.]]></dc:creator>
<dc:date>2009-06-16</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp144</dc:identifier>
<dc:title><![CDATA[CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-16</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp154v1?rss=1">
<title><![CDATA[Bidirectional alterations of interhemispheric parietal balance by non-invasive cortical stimulation]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp154v1?rss=1</link>
<description><![CDATA[
<p>Transcranial direct current stimulation is a painless, non-invasive brain stimulation technique that allows one to induce polarity-specific excitability changes in the human brain. Here, we investigated, for the first time in a &lsquo;proof of principle&rsquo; study, the behavioural effect of transcranial direct current stimulation on visuospatial attention in both healthy controls and stroke patients suffering from left visuospatial neglect. We applied anodal, cathoP:dal or sham transcranial direct current stimulation (57 &micro;A/cm<sup>2</sup>, 10 min) to the left or right posterior parietal cortex. Using a visual detection task in a group of right-handed healthy individuals (<I>n</I> = 20), we observed that transcranial direct current stimulation enhanced or impaired performance depending on stimulation parameters (i.e. current polarity) and stimulated hemisphere. These results are in good accordance with classic models of reciprocal interhemispheric competition (&lsquo;rivalry&rsquo;). In a second experiment, we investigated the potential of transcranial direct current stimulation to ameliorate left visuospatial neglect (<I>n</I> = 10). Interestingly, both the inhibitory effect of cathodal transcranial direct current stimulation applied over the unlesioned posterior parietal cortex and the facilitatory effect of anodal transcranial direct current stimulation applied over the lesioned posterior parietal cortex reduced symptoms of visuospatial neglect. Taken together, our findings suggest that transcranial direct current stimulation applied over the posterior parietal cortex can be used to modulate visuospatial processing and that this effect is exerted by influencing interhemispheric reciprocal networks. These novel findings also suggest that a transcranial direct current stimulation-induced modulation of interhemispheric parietal balance may be used clinically to ameliorate visuospatial attention deficits in neglect patients.</p>
]]></description>
<dc:creator><![CDATA[Sparing, R., Thimm, M., Hesse, M. D., Kust, J., Karbe, H., Fink, G. R.]]></dc:creator>
<dc:date>2009-06-15</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp154</dc:identifier>
<dc:title><![CDATA[Bidirectional alterations of interhemispheric parietal balance by non-invasive cortical stimulation]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-15</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp147v1?rss=1">
<title><![CDATA[The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp147v1?rss=1</link>
<description><![CDATA[
<p>Upon central nervous system injury, the extracellular concentrations of nucleotides and cysteinyl-leukotrienes, two unrelated families of endogenous signalling molecules, are markedly increased at the site of damage, suggesting that they may act as &lsquo;danger signals&rsquo; to alert responses to tissue damage and start repair. Here we show that, in non-injured spinal cord parenchyma, GPR17, a P2Y-like receptor responding to both uracil nucleotides (e.g. UDP-glucose) and cysteinyl-leukotrienes (e.g. LTD<SUB>4</SUB> and LTC<SUB>4</SUB>), is present on a subset of neurons and of oligodendrocytes at different stages of maturation, whereas it is not expressed by astrocytes. GPR17 immunoreactivity was also found on ependymal cells lining the central canal that still retain some of the characteristics of stem/progenitor cells during adulthood. Induction of spinal cord injury (SCI) by acute compression resulted in marked cell death of GPR17<sup>+</sup> neurons and oligodendrocytes inside the lesion followed by the appearance of proliferating GPR17<sup>+</sup> microglia/macrophages migrating to and infiltrating into the lesioned area. Moreover, 72 h after SCI, GPR17<sup>+</sup> ependymal cells started to proliferate and to express GFAP, suggesting their activation and &lsquo;de-differentiation&rsquo; to pluripotent progenitor cells. The <I>in vivo</I> knock down of GPR17 by an antisense oligonucleotide strategy during SCI induction markedly reduced tissue damage and related histological and motor deficits, thus confirming the crucial role played by this receptor in the early phases of tissue damage development. Taken together, our findings suggest a dual and spatiotemporal-dependent role for GPR17 in SCI. At very early times after injury, GPR17 mediates neuronal and oligodendrocyte death inside the lesioned area. At later times, GPR17<sup>+</sup> microglia/macrophages are recruited from distal parenchymal areas and move toward the lesioned zone, to suggest a role in orchestrating local remodelling responses. At the same time, the induction of the stem cell marker GFAP in GPR17<sup>+</sup> ependymal cells suggests initiation of repair mechanisms. Thus, GPR17 may act as a &lsquo;sensor&rsquo; of damage that is activated by nucleotides and cysteinyl-leukotrienes released in the lesioned area, and could also participate in post-injury responses. Moreover, its presence on spinal cord pre-oligodendrocytes and precursor-like cells suggests GPR17 as a novel target for therapeutic manipulation to foster remyelination and functional repair in SCI.</p>
]]></description>
<dc:creator><![CDATA[Ceruti, S., Villa, G., Genovese, T., Mazzon, E., Longhi, R., Rosa, P., Bramanti, P., Cuzzocrea, S., Abbracchio, M. P.]]></dc:creator>
<dc:date>2009-06-15</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp147</dc:identifier>
<dc:title><![CDATA[The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-15</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp158v1?rss=1">
<title><![CDATA[Gene-environment interactions in Leber hereditary optic neuropathy]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp158v1?rss=1</link>
<description><![CDATA[
<p>Leber hereditary optic neuropathy (LHON) is a genetic disorder primarily due to mutations of mitochondrial DNA (mtDNA). Environmental factors are thought to precipitate the visual failure and explain the marked incomplete penetrance of LHON, but previous small studies have failed to confirm this to be the case. LHON has no treatment, so identifying environmental triggers is the key to disease prevention, whilst potentially revealing new mechanisms amenable to therapeutic manipulation. To address this issue, we conducted a large, multicentre epidemiological study of 196 affected and 206 unaffected carriers from 125 LHON pedigrees known to harbour one of the three primary pathogenic mtDNA mutations: m.3460G&gt;A, m.11778G&gt;A and m.14484T&gt;C. A comprehensive history of exposure to smoking, alcohol and other putative environmental insults was collected using a structured questionnaire. We identified a strong and consistent association between visual loss and smoking, independent of gender and alcohol intake, leading to a clinical penetrance of 93% in men who smoked. There was a trend towards increased visual failure with alcohol, but only with a heavy intake. Based on these findings, asymptomatic carriers of a LHON mtDNA mutation should be strongly advised not to smoke and to moderate their alcohol intake.</p>
]]></description>
<dc:creator><![CDATA[Kirkman, M. A., Yu-Wai-Man, P., Korsten, A., Leonhardt, M., Dimitriadis, K., De Coo, I. F., Klopstock, T., Chinnery, P. F.]]></dc:creator>
<dc:date>2009-06-12</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp158</dc:identifier>
<dc:title><![CDATA[Gene-environment interactions in Leber hereditary optic neuropathy]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-12</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp157v1?rss=1">
<title><![CDATA[Semantic memory activation in amnestic mild cognitive impairment]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp157v1?rss=1</link>
<description><![CDATA[
<p>Cognitively intact older individuals at risk for developing Alzheimer's disease frequently show increased functional magnetic resonance imaging (fMRI) brain activation presumably associated with compensatory recruitment, whereas mild cognitive impairment (MCI) patients tend not to show increased activation presumably due to reduced neural reserve. Previous studies, however, have typically used episodic memory activation tasks, placing MCI participants at a performance disadvantage relative to healthy elders. In this event-related fMRI study, we employed a low effort, high accuracy semantic memory task to determine if increased activation of memory circuits is preserved in amnestic MCI when task performance is controlled. Fifty-seven participants, aged 65&ndash;85 years, comprised three groups (<I>n</I> = 19 each): amnestic MCI patients; cognitively intact older participants at risk for developing Alzheimer's disease based on having at least one ApoE 4 allele and a positive family history of Alzheimer's disease (At Risk); and cognitively intact participants without Alzheimer's disease risk factors (Control). fMRI was conducted on a 3T MR scanner while participants performed a famous name discrimination task. Participants also underwent neuropsychological testing outside the scanner; whole brain and hippocampal atrophy were assessed from anatomical MRI scans. The three groups did not differ on demographic variables or on fame discrimination performance (&gt;87% correct for all groups). As expected, the amnestic MCI participants demonstrated reduced episodic memory performance. Spatial extent of activation (Fame&mdash;Unfamiliar subtraction) differentiated the three groups (Control = 0 ml, At Risk = 9.7 ml, MCI = 34.7 ml). The MCI and At Risk groups showed significantly greater per cent signal change than Control participants in 8 of 14 functionally defined regions, including the medial temporal lobe, temporoparietal junction, and posterior cingulate/precuneus. MCI participants also showed greater activation than Controls in two frontal regions. At Risk, but not MCI, participants showed increased activity in the left hippocampal complex; MCI participants, however, evidenced increased activity in this region when hippocampal atrophy was controlled. When performance is equated, MCI patients demonstrate functional compensation in brain regions subserving semantic memory systems that generally equals or exceeds that observed in cognitively intact individuals at risk for Alzheimer's disease. This hyperactivation profile in MCI is even observed in the left hippocampal complex, but only when the extent of hippocampal atrophy is taken into consideration.</p>
]]></description>
<dc:creator><![CDATA[Woodard, J. L., Seidenberg, M., Nielson, K. A., Antuono, P., Guidotti, L., Durgerian, S., Zhang, Q., Lancaster, M., Hantke, N., Butts, A., Rao, S. M.]]></dc:creator>
<dc:date>2009-06-10</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp157</dc:identifier>
<dc:title><![CDATA[Semantic memory activation in amnestic mild cognitive impairment]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-10</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp155v1?rss=1">
<title><![CDATA[The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp155v1?rss=1</link>
<description><![CDATA[
<p>It is unknown whether collateral vessel status, as seen on computed tomography angiography, can predict the fate of penumbral tissue identified on perfusion computed tomography and thereby influence clinical outcome. We tested this hypothesis in consecutive patients who underwent perfusion computed tomography/computed tomography angiography within 6 h of anterior circulation stroke, who also had repeat perfusion/infarct volume imaging at 24 h, and modified Rankin Scale at 3 months. Collateral status was graded as good or reduced depending on the extent of contrast visualized distal to the occlusion on computed tomography angiography. &lsquo;Perfusion computed tomography mismatch&rsquo; ratio was calculated from the ratio of the mean transit time lesion/cerebral blood volume lesion. Of 92 patients with proximal intracranial vessel occlusion, good collateral status (51/92) was significantly associated with reduced infarct expansion and more favourable functional outcomes (modified Rankin Scale 0&ndash;2). Significant univariate predictors of favourable outcome were good collateral status, major reperfusion at 24 h, presence of perfusion computed tomography mismatch (for a range of ratios: &ge;1.2, &ge;2, &ge;3, &ge;3.5) and baseline National Institutes of Health Stroke Scale score. Notably, none of the 37 patients with a perfusion computed tomography mismatch ratio &lt; 3.0 had a favourable outcome. In patients with perfusion computed tomography mismatch, significant independent predictors of favourable outcome were good collateral status, major reperfusion and baseline National Institutes of Health Stroke Scale score. There was also a strong interaction between major reperfusion and good collateral status in the regression models. In patients with proximal vessel occlusion, perfusion computed tomography mismatch is a prerequisite for a favourable clinical response, but good collateral status appears a critical determinant of ultimate outcome, particularly if major reperfusion occurs.</p>
]]></description>
<dc:creator><![CDATA[Miteff, F., Levi, C. R., Bateman, G. A., Spratt, N., McElduff, P., Parsons, M. W.]]></dc:creator>
<dc:date>2009-06-09</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp155</dc:identifier>
<dc:title><![CDATA[The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-09</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp153v1?rss=1">
<title><![CDATA[Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp153v1?rss=1</link>
<description><![CDATA[
<p>Polypyrimidine tract-binding protein 1 (PTBP1) is a multi-functional RNA-binding protein that is aberrantly overexpressed in glioma. PTBP1 and its brain-specific homologue polypyrimidine tract-binding protein 2 (PTBP2) regulate neural precursor cell differentiation. However, the overlapping and non-overlapping target transcripts involved in this process are still unclear. To determine why PTBP1 and not PTBP2 would promote glial cell-derived tumours, both PTBP1 and PTBP2 were knocked down in the human glioma cell lines U251 and LN229 to determine the role of these proteins in cell proliferation, migration, and adhesion. Surprisingly, removal of both PTBP1 and PTBP2 slowed cell proliferation, with the double knockdown having no additive effects. Decreased expression of both proteins individually and in combination inhibited cell migration and increased adhesion of cells to fibronectin and vitronectin. A global survey of differential exon expression was performed following PTBP1 knockdown in U251 cells using the Affymetrix Exon Array to identify PTBP1-specific splicing targets that enhance gliomagenesis. In the PTBP1 knockdown, previously determined targets were unaltered in their splicing patterns. A single gene, <I>RTN4</I> (Nogo) had significantly enhanced inclusion of exon 3 when PTBP1 was removed. Overexpression of the splice isoform containing exon 3 decreased cell proliferation to a similar degree as the removal of PTBP1. These results provide the first evidence that RNA-binding proteins affect the invasive and rapid growth characteristics of glioma cell lines. Its actions on proliferation appear to be mediated, in part, through alternative splicing of <I>RTN4</I>.</p>
]]></description>
<dc:creator><![CDATA[Cheung, H. C., Hai, T., Zhu, W., Baggerly, K. A., Tsavachidis, S., Krahe, R., Cote, G. J.]]></dc:creator>
<dc:date>2009-06-08</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp153</dc:identifier>
<dc:title><![CDATA[Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-08</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp146v1?rss=1">
<title><![CDATA[Different impairments of semantic cognition in semantic dementia and semantic aphasia: evidence from the non-verbal domain]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp146v1?rss=1</link>
<description><![CDATA[
<p>Disorders of semantic cognition in different neuropsychological conditions result from diverse areas of brain damage and may have different underlying causes. This study used a comparative case-series design to examine the hypothesis that relatively circumscribed bilateral atrophy of the anterior temporal lobe in semantic dementia (SD) produces a gradual degradation of core semantic representations, whilst a deficit of cognitive control produces multi-modal semantic impairment in a subset of patients with stroke aphasia following damage involving the left prefrontal cortex or regions in and around the temporoparietal area; this condition, which transcends traditional aphasia classifications, is referred to as &lsquo;semantic aphasia&rsquo; (SA). There have been very few direct comparisons of these patient groups to date and these previous studies have focussed on verbal comprehension. This study used a battery of object-use tasks to extend this line of enquiry into the non-verbal domain for the first time. A group of seven SA patients were identified who failed both word and picture versions of a semantic association task. These patients were compared with eight SD cases. Both groups showed significant deficits in object use but these impairments were qualitatively different. Item familiarity correlated with performance on object-use tasks for the SD group, consistent with the view that core semantic representations are degrading in this condition. In contrast, the SA participants were insensitive to the familiarity of the objects. Further, while the SD patients performed consistently across tasks that tapped different aspects of knowledge and object use for the same items, the performance of the SA participants reflected the control requirements of the tasks. Single object use was relatively preserved in SA but performance on complex mechanical puzzles was substantially impaired. Similarly, the SA patients were able to complete straightforward item matching tasks, such as word-picture matching, but performed more poorly on associative picture-matching tasks, even when the tests involved the same items. The two groups of patients also showed a different pattern of errors in object use. SA patients made substantial numbers of erroneous intrusions in their demonstrations, such as inappropriate object movements. In contrast, response omissions were more common in SD. This study provides converging evidence for qualitatively different impairments of semantic cognition in SD and SA, and uniquely demonstrates this pattern in a non-verbal expressive domain&mdash;object use.</p>
]]></description>
<dc:creator><![CDATA[Corbett, F., Jefferies, E., Ehsan, S., Lambon Ralph, M. A.]]></dc:creator>
<dc:date>2009-06-08</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp146</dc:identifier>
<dc:title><![CDATA[Different impairments of semantic cognition in semantic dementia and semantic aphasia: evidence from the non-verbal domain]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-08</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp145v1?rss=1">
<title><![CDATA[Multi-focal occurrence of cortical dysplasia in epilepsy patients]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp145v1?rss=1</link>
<description><![CDATA[
<p>This study describes the existence and the clinical and electrophysiological features of multi-focal cortical dysplasia in epilepsy patients. Five patients with intractable focal epilepsy are reported. All patients underwent invasive presurgical video-electroencephalography monitoring. Localization of dysplastic areas was based on high-resolution magnetic resonance scanning, surface and intracranial electroencephalography. Four patients underwent epilepsy surgery. Histological findings in focal cortical dysplasia (FCD) were classified according to Palmini. In addition, genetic examinations were performed in order to assess possible mutations in the genes for tuberous sclerosis complex. In four patients, FCDs were located in the same hemisphere. One case presented with bilateral FCDs. In three patients seizures arose from two separate dysplastic areas and in one patient, one lesion showed only interictal activity. In one further patient, seizures started exclusively from the hippocampus. In two of three patients with removal of the FCDs, the histological subtype was identical (Palmini type 2) and in one patient, histology differed between the lesions. All operated patients became seizure-free. In patients with FCD type 2, germ-line mutations in the tuberous sclerosis complex genes were not detectable. Dysplastic brain regions may not be restricted to a single brain region. Areas of FCD can have different degrees of epileptogenicity, ranging from electrographic silence to interictal epileptic discharges and initial involvement in seizure generation. Based on genetic analysis and clinical features, multi-FCD in this patient series was not likely to be related to tuberous sclerosis.</p>
]]></description>
<dc:creator><![CDATA[Fauser, S., Sisodiya, S. M., Martinian, L., Thom, M., Gumbinger, C., Huppertz, H.-J., Hader, C., Strobl, K., Steinhoff, B. J., Prinz, M., Zentner, J., Schulze-Bonhage, A.]]></dc:creator>
<dc:date>2009-06-08</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp145</dc:identifier>
<dc:title><![CDATA[Multi-focal occurrence of cortical dysplasia in epilepsy patients]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-08</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp142v1?rss=1">
<title><![CDATA[The neurophysiological correlates of motor tics following focal striatal disinhibition]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp142v1?rss=1</link>
<description><![CDATA[
<p>The cortico-basal ganglia pathway is involved in normal motor control and implicated in multiple movement disorders. Brief repetitive muscle contractions known as motor tics are a common symptom in several basal ganglia related motor disorders. We used focal micro-injections of the GABA-A antagonist bicuculline to the sensorimotor putamen of behaving primates to induce stereotyped tics similar to those observed in human disorders. This focal disruption of GABA transmission in the putamen led to motor tics confined to a single or a few muscles. The temporal and structural properties of the tics were identified using electromyogram and frame-by-frame analysis of multi-camera video recordings. During experimental sessions the tics would wax and wane, but their size and shape remained highly stereotyped within the session. Neuronal spiking activity and local field potentials were recorded simultaneously from multiple locations along the cortico-basal ganglia pathway: motor cortex, putamen and globus pallidus external and internal segments. The local field potentials displayed stereotyped tic-related voltage transients lasting several hundred milliseconds. These &lsquo;local field potential spikes&rsquo;, which appeared throughout the cortico-basal ganglia pathway, were consistently observed in close temporal association to the motor tics. During tic expression, neuronal activity was altered in most of the recorded neurons in a temporally focal manner, displaying phasic firing rate modulations time locked to the tics. Consistent with theoretical models of tic generation, transient inhibition of the basal ganglia output nucleus prior to and during tic expression was observed. The phasic reduction of basal ganglia output was correlated with a disinhibition of cortical activity, manifesting as short bursts of activity in motor cortex. The results demonstrate that the basal ganglia provide a finely timed disinhibition in the output nuclei of the basal ganglia. However, a large fraction of the neurons were simultaneously inhibited during tics, although tics were only manifested in a small confined muscle group. This suggests that rather than representing a specific action within the basal ganglia itself, these nuclei provide a temporally exact but spatially distributed release signal. The tics induced by striatal disinhibition bear a striking resemblance to motor tics recognized in human pathologies associated with basal ganglia dysfunction. The neuronal changes observed during tic formation may provide valuable insights into the underlying mechanism of tic disorders, as well as into basic information processing in the cortico-basal ganglia loop.</p>
]]></description>
<dc:creator><![CDATA[McCairn, K. W., Bronfeld, M., Belelovsky, K., Bar-Gad, I.]]></dc:creator>
<dc:date>2009-06-08</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp142</dc:identifier>
<dc:title><![CDATA[The neurophysiological correlates of motor tics following focal striatal disinhibition]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-08</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp138v1?rss=1">
<title><![CDATA[Neurology of anomia in the semantic variant of primary progressive aphasia]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp138v1?rss=1</link>
<description><![CDATA[
<p>The semantic variant of primary progressive aphasia (PPA) is characterized by the combination of word comprehension deficits, fluent aphasia and a particularly severe anomia. In this study, two novel tasks were used to explore the factors contributing to the anomia. The single most common factor was a blurring of distinctions among members of a semantic category, leading to errors of overgeneralization in word&ndash;object matching tasks as well as in word definitions and object descriptions. This factor was more pronounced for natural kinds than artifacts. In patients with the more severe anomias, conceptual maps were more extensively disrupted so that inter-category distinctions were as impaired as intra-category distinctions. Many objects that could not be named aloud could be matched to the correct word in patients with mild but not severe anomia, reflecting a gradual intensification of the semantic factor as the naming disorder becomes more severe. Accurate object descriptions were more frequent than accurate word definitions and all patients experienced prominent word comprehension deficits that interfered with everyday activities but no consequential impairment of object usage or face recognition. Magnetic resonance imaging revealed three characteristics: greater atrophy of the left hemisphere; atrophy of anterior components of the perisylvian language network in the superior and middle temporal gyri; and atrophy of anterior components of the face and object recognition network in the inferior and medial temporal lobes. The left sided asymmetry and perisylvian extension of the atrophy explains the more profound impairment of word than object usage and provides the anatomical basis for distinguishing the semantic variant of primary progressive aphasia from the partially overlapping group of patients that fulfil the widely accepted diagnostic criteria for semantic dementia.</p>
]]></description>
<dc:creator><![CDATA[Mesulam, M., Rogalski, E., Wieneke, C., Cobia, D., Rademaker, A., Thompson, C., Weintraub, S.]]></dc:creator>
<dc:date>2009-06-08</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp138</dc:identifier>
<dc:title><![CDATA[Neurology of anomia in the semantic variant of primary progressive aphasia]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-08</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp161v1?rss=1">
<title><![CDATA[Differential phenotype in Parkinson's disease patients with severe versus mild GBA mutations]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp161v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Gan-Or, Z., Giladi, N., Orr-Urtreger, A.]]></dc:creator>
<dc:date>2009-06-05</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp161</dc:identifier>
<dc:title><![CDATA[Differential phenotype in Parkinson's disease patients with severe versus mild GBA mutations]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-05</prism:publicationDate>
<prism:section>Letter to the Editor</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp137v1?rss=1">
<title><![CDATA[Interictal magnetoencephalography and the irritative zone in the electrocorticogram]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp137v1?rss=1</link>
<description><![CDATA[
<p>Magnetoencephalography (MEG) is considered a useful tool for planning electrode placement for chronic intracranial subdural electrocorticography (ECoG) in candidates for epilepsy surgery or even as a substitute for ECoG. MEG recordings are usually interictal and therefore, at best, reflect the interictal ECoG. To estimate the clinical value of MEG, it is important to know how well interictal MEG reflects interictal activity in the ECoG. From 1998 to 2008, 38 candidates for ECoG underwent a 151-channel MEG recording and 3D magnetic resonance imaging as a part of their presurgical evaluation. Interictal MEG spikes were identified, clustered, averaged and modelled using the multiple signal classification algorithm and co-registered to magnetic resonance imaging. ECoG was continuously recorded with electrode grids and strips for ~1 week. In a representative sample of awake interictal ECoG, interictal spikes were identified and averaged. The different spikes were characterized and quantified using a combined amplitude and synchronous surface&ndash;area measure. The ECoG spikes were ranked according to this measure and plotted on the magnetic resonance imaging surface rendering. Interictal spikes in MEG and ECoG were allocated to a predefined anatomical brain region and an association analysis was performed. All interictal MEG spikes were associated with an interictal ECoG spike. Overall, 56% of all interictal ECoG spikes had an interictal MEG counterpart. The association between the two was &ge;90% in the interhemispheric and frontal orbital region, ~75% in the superior frontal, central and lateral temporal regions, but only ~25% in the mesial temporal region. MEG is a reliable indicator of the presence of interictal ECoG spikes and can be used to plan intracranial electrode placements. However, a substantial number of interictal ECoG spikes are not detected by MEG, and therefore MEG cannot be considered a substitute for ECoG.</p>
]]></description>
<dc:creator><![CDATA[Agirre-Arrizubieta, Z., Huiskamp, G. J. M., Ferrier, C. H., van Huffelen, A. C., Leijten, F. S. S.]]></dc:creator>
<dc:date>2009-06-04</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp137</dc:identifier>
<dc:title><![CDATA[Interictal magnetoencephalography and the irritative zone in the electrocorticogram]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-06-04</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp132v1?rss=1">
<title><![CDATA[Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp132v1?rss=1</link>
<description><![CDATA[
<p>A sensitive marker for monitoring progression of early Alzheimer's disease would help to develop and test new therapeutic strategies. The present study is aimed at investigating brain metabolism changes over time, as a potential monitoring marker, in patients with amnestic mild cognitive impairment, according to their clinical outcome (converters or non-converters), and in relation to their cognitive decline. Seventeen amnestic mild cognitive impairment patients underwent magnetic resonance imaging and <sup>18</sup>FDG-positron emission tomography scans both at inclusion and 18 months later. Baseline and follow-up positron emission tomography data were corrected for partial volume effects and spatially normalized using magnetic resonance imaging data, scaled to the vermis and compared using SPM2. &lsquo;PET-PAC&rsquo; maps reflecting metabolic per cent annual changes were created for correlation analyses with cognitive decline. In the whole sample, the greatest metabolic decrease concerned the posterior cingulate-precuneus area. Converters had significantly greater metabolic decrease than non-converters in two ventro-medial prefrontal areas, the subgenual (BA25) and anterior cingulate (BA24/32). PET-PAC in BA25 and BA24/32 combined allowed complete between-group discrimination. BA25 PET-PAC significantly correlated with both cognitive decline and PET-PAC in the hippocampal region and temporal pole, while BA24/32 PET-PAC correlated with posterior cingulate PET-PAC. Finally, the metabolic change in BA8/9/10 was inversely related to that in BA25 and showed relative increase with cognitive decline, suggesting that compensatory processes may occur in this dorso-medial prefrontal region. The observed ventro-medial prefrontal disruption is likely to reflect disconnection from the hippocampus, both indirectly through the cingulum bundle and posterior cingulate cortex for BA24/32, and directly through the uncinate fasciculus for BA25. Altogether, our findings emphasize the potential of <sup>18</sup>FDG-positron emission tomography for monitoring early Alzheimer's disease progression.</p>
]]></description>
<dc:creator><![CDATA[Fouquet, M., Desgranges, B., Landeau, B., Duchesnay, E., Mezenge, F., de la Sayette, V., Viader, F., Baron, J.-C., Eustache, F., Chetelat, G.]]></dc:creator>
<dc:date>2009-05-28</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp132</dc:identifier>
<dc:title><![CDATA[Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-28</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp126v1?rss=1">
<title><![CDATA[Schizophrenia delays and alters maturation of the brain in adolescence]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp126v1?rss=1</link>
<description><![CDATA[
<p>Early-onset schizophrenia appears to be clinically more severe than the adult-onset form of the disease. In a previous study, we showed that anatomically related grey and white matter abnormalities found in adolescents patients were larger and more widespread than what had been reported in the literature on adult schizophrenia. Particularly, we found novel structural abnormalities in the primary sensorimotor and premotor systems. Here, we tested alternative hypotheses: either this striking sensorimotor-related pattern is an artefact due to a better sensitivity of the methods, or apparent greater structural abnormalities in the early-onset population are <I>specifically</I> associated with earlier disease onset. Then, if we were to find such characteristic structural pattern, we would test whether these anatomical abnormalities would remain static or, conversely, show dynamic changes in the still developing brain. To address these questions, we combined a cross-sectional study of brain structure for adolescent-onset patients (<I>n</I> = 25) and adult-onset patients (<I>n</I> = 35) and respective matched healthy subjects with a longitudinal study of adolescent-onset patients (<I>n</I> = 12, representative subset of the cross-sectional group) and matched healthy controls for &gt;2 years. Looking at differences between adolescent and adult patients&rsquo; grey matter volume and white matter microstructure abnormalities, we first confirmed the specificity (especially in motor-related areas) and the greater severity of structural abnormalities in the adolescent patients. Closer examination revealed, however, that such greater anomalies seemed to arise because adolescent patients fail to follow the same developmental time course as the healthy control group. Longitudinal analysis of a representative subset of the adolescent patient and matched healthy populations corroborated the delayed and altered maturation in both grey and white matters. Structural abnormalities specific to adolescent-onset schizophrenia in the sensori-motor cortices and corticospinal tract were less marked or even disappeared within the longitudinal period of observation, grey matter abnormalities in adolescent patients evolving towards the adult-onset pattern as defined by recent meta-analyses of adult schizophrenia. Combining cross-sectional adolescent and adult datasets with longitudinal adolescent dataset allowed us to find a unique, abnormal trajectory of grey matter maturation regardless of the age at onset of symptoms and of disease duration, with a lower and later peak than for healthy subjects. Taken together, these results suggest common aetiological mechanisms for adolescent- and adult-onset schizophrenia with an altered neurodevelopmental time course in the schizophrenic patients that is particularly salient in adolescence.</p>
]]></description>
<dc:creator><![CDATA[Douaud, G., Mackay, C., Andersson, J., James, S., Quested, D., Ray, M. K., Connell, J., Roberts, N., Crow, T. J., Matthews, P. M., Smith, S., James, A.]]></dc:creator>
<dc:date>2009-05-28</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp126</dc:identifier>
<dc:title><![CDATA[Schizophrenia delays and alters maturation of the brain in adolescence]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-28</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp125v1?rss=1">
<title><![CDATA[Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp125v1?rss=1</link>
<description><![CDATA[
<p>Restless leg syndrome (RLS) is a sensorimotor disorder. Clinical studies have implicated the dopaminergic system in RLS, while others have suggested that it is associated with insufficient levels of brain iron. To date, alterations in brain iron status have been demonstrated but, despite suggestions from the clinical literature, there have been no consistent findings documenting a dopaminergic abnormality in RLS brain tissue. In this study, the substantia nigra and putamen were obtained at autopsy from individuals with primary RLS and a neurologically normal control group. A quantitative profile of the dopaminergic system was obtained. Additional assays were performed on a catecholaminergic cell line and animal models of iron deficiency. RLS tissue, compared with controls, showed a significant decrease in D2R in the putamen that correlated with severity of the RLS. RLS also showed significant increases in tyrosine hydroxylase (TH) in the substantia nigra, compared with the controls, but not in the putamen. Both TH and phosphorylated (active) TH were significantly increased in both the substantia nigra and putamen. There were no significant differences in either the putamen or nigra for dopamine receptor 1, dopamine transporters or for VMAT. Significant increases in TH and phosphorylated TH were also seen in both the animal and cell models of iron insufficiency similar to that from the RLS autopsy data. For the first time, a clear indication of dopamine pathology in RLS is revealed in this autopsy study. The results suggest cellular regulation of dopamine production that closely matches the data from cellular and animal iron insufficiency models. The results are consistent with the hypothesis that a primary iron insufficiency produces a dopaminergic abnormality characterized as an overly activated dopaminergic system as part of the RLS pathology.</p>
]]></description>
<dc:creator><![CDATA[Connor, J. R., Wang, X.-S., Allen, R. P., Beard, J. L., Wiesinger, J. A., Felt, B. T., Earley, C. J.]]></dc:creator>
<dc:date>2009-05-25</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp125</dc:identifier>
<dc:title><![CDATA[Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-25</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp143v1?rss=1">
<title><![CDATA[Corrigendum]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp143v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2009-05-21</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp143</dc:identifier>
<dc:title><![CDATA[Corrigendum]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-21</prism:publicationDate>
<prism:section>Corrigendum</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp124v1?rss=1">
<title><![CDATA[Changes in spinal reflex and locomotor activity after a complete spinal cord injury: a common mechanism?]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp124v1?rss=1</link>
<description><![CDATA[
<p>Locomotor activity and spinal reflexes (SRs) show common features in different mammals, including humans. Here we report the time-course of the development of locomotor activity and SRs after a complete spinal cord injury in humans. SRs evoked by tibial nerve stimulation were studied, as was the leg muscle electromyography activity evoked by mechanically assisted locomotion (Lokomat) in biceps femoris, rectus femoris, tibialis anterior and gastrocenmius medialis. Around 8 weeks after the injury, an early SR component (latency 60&ndash;120 ms) appeared, as in healthy subjects, and a well-organized leg muscle activity was present during assisted locomotion. At around 6 months after injury an additional, late reflex component (latency 120&ndash;450 ms) appeared, which remained even 15 years after the spinal cord injury. In contrast, the early component had markedly decreased at 18 months after injury. These changes in SR were associated with a loss of electromyography activity and a successively stronger electromyography exhaustion (i.e. decline of electromyography amplitude), when comparing the level of electromyography activity at 2 and 10 min, respectively, during assisted locomotion. These changes in electromyography activity affected mainly the biceps femoris, gastrocenmius medialis and tibialis anterior but less so the rectus femoris. When the amplitude relationship of the early to late SR component was calculated, there was a temporal relationship between the decrease of the early component and an increase of the late component and the degree of exhaustion of locomotor activity. In chronic, severely affected but sensori-motor incomplete spinal cord injury subjects a late SR component, associated with an electromyography exhaustion, was present in subjects who did not regularly perform stepping movements. Our data are consistent with the proposal of a common mechanism underlying the changes in SR activity and locomotor activity after spinal cord injury. These findings should be taken into consideration in the development of novel rehabilitation schemes and programs to facilitate regeneration-inducing therapies in spinal cord injury subjects.</p>
]]></description>
<dc:creator><![CDATA[Dietz, V., Grillner, S., Trepp, A., Hubli, M., Bolliger, M.]]></dc:creator>
<dc:date>2009-05-21</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp124</dc:identifier>
<dc:title><![CDATA[Changes in spinal reflex and locomotor activity after a complete spinal cord injury: a common mechanism?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-21</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp123v1?rss=1">
<title><![CDATA[Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp123v1?rss=1</link>
<description><![CDATA[
<p>Mild cognitive impairment can represent a transitional state between normal ageing and Alzheimer's disease. Non-invasive diagnostic methods are needed to identify mild cognitive impairment individuals for early therapeutic interventions. Our objective was to determine whether automated magnetic resonance imaging-based measures could identify mild cognitive impairment individuals with a high degree of accuracy. Baseline volumetric T<SUB>1</SUB>-weighted magnetic resonance imaging scans of 313 individuals from two independent cohorts were examined using automated software tools to identify the volume and mean thickness of 34 neuroanatomic regions. The first cohort included 49 older controls and 48 individuals with mild cognitive impairment, while the second cohort included 94 older controls and 57 mild cognitive impairment individuals. Sixty-five patients with probable Alzheimer's disease were also included for comparison. For the discrimination of mild cognitive impairment, entorhinal cortex thickness, hippocampal volume and supramarginal gyrus thickness demonstrated an area under the curve of 0.91 (specificity 94%, sensitivity 74%, positive likelihood ratio 12.12, negative likelihood ratio 0.29) for the first cohort and an area under the curve of 0.95 (specificity 91%, sensitivity 90%, positive likelihood ratio 10.0, negative likelihood ratio 0.11) for the second cohort. For the discrimination of Alzheimer's disease, these three measures demonstrated an area under the curve of 1.0. The three magnetic resonance imaging measures demonstrated significant correlations with clinical and neuropsychological assessments as well as with cerebrospinal fluid levels of tau, hyperphosphorylated tau and abeta 42 proteins. These results demonstrate that automated magnetic resonance imaging measures can serve as an <I>in vivo</I> surrogate for disease severity, underlying neuropathology and as a non-invasive diagnostic method for mild cognitive impairment and Alzheimer's disease.</p>
]]></description>
<dc:creator><![CDATA[Desikan, R. S., Cabral, H. J., Hess, C. P., Dillon, W. P., Glastonbury, C. M., Weiner, M. W., Schmansky, N. J., Greve, D. N., Salat, D. H., Buckner, R. L., Fischl, B., Alzheimer's Disease Neuroimaging Initiative]]></dc:creator>
<dc:date>2009-05-21</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp123</dc:identifier>
<dc:title><![CDATA[Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-21</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp063v1?rss=1">
<title><![CDATA[A textbook for every neurologist]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp063v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Hildebrand, J. G.]]></dc:creator>
<dc:date>2009-05-18</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp063</dc:identifier>
<dc:title><![CDATA[A textbook for every neurologist]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-18</prism:publicationDate>
<prism:section>Book Review</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp100v1?rss=1">
<title><![CDATA['The quicksand of forgetfulness': semantic dementia in One Hundred Years of Solitude]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp100v1?rss=1</link>
<description><![CDATA[
<p>This multidisciplinary article compares the pattern of memory loss described in Gabriel Garc&iacute;a M&aacute;rquez's <I>One Hundred Years of Solitude</I> to that exhibited by patients with semantic dementia (SD). In his renowned novel, Garc&iacute;a M&aacute;rquez depicts the plight of Macondo, a town struck by the dreaded insomnia plague. The most devastating symptom of the plague is not the impossibility of sleep, but rather the loss of &lsquo;the name and notion of things&rsquo;. In an effort to combat this insidious loss of knowledge, the protagonist, Jos&eacute; Arcadio Buend&iacute;a, &lsquo;marked everything with its name: <I>table, chair, clock, door, wall, bed, pan&rsquo;</I>. &lsquo;Studying the infinite possibilities of a loss of memory, he realized that the day might come when things would be recognized by their inscriptions but that no one would remember their use&rsquo;. The cognitive impairments experienced by Macondo's inhabitants are remarkably similar to those observed in SD, a clinical syndrome characterized by a progressive breakdown of conceptual knowledge (semantic memory) in the context of relatively preserved day-to-day (episodic) memory. First recognized in 1975, it is now considered one of the main variants of frontotemporal lobar degeneration. Writing within the realm of magical realism and investigating the power of language as a form of communication, Garc&iacute;a M&aacute;rquez provides beautiful descriptions of the loss of &lsquo;the name and notion of things&rsquo; typical of the syndrome. He further speculates on ways to cope with this dissolution of meaning, ranging from &lsquo;the spell of an imaginary reality&rsquo; to Jos&eacute; Arcadio's &lsquo;memory machine&rsquo;, strategies that resonate with attempts by semantic dementia patients to cope with their disease. Remarkably, Garc&iacute;a M&aacute;rquez created a striking literary depiction of collective semantic dementia before the syndrome was recognized in neurology. The novel also provides an inspiring and human account of one town's fight against &lsquo;the quicksand of forgetfulness&rsquo;.</p>
]]></description>
<dc:creator><![CDATA[Rascovsky, K., Growdon, M. E., Pardo, I. R., Grossman, S., Miller, B. L.]]></dc:creator>
<dc:date>2009-05-15</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp100</dc:identifier>
<dc:title><![CDATA['The quicksand of forgetfulness': semantic dementia in One Hundred Years of Solitude]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-15</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp117v1?rss=1">
<title><![CDATA[Imbalance of neural cell adhesion molecule and polysialyltransferase alleles causes defective brain connectivity]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp117v1?rss=1</link>
<description><![CDATA[
<p>The neural cell adhesion molecule (NCAM) and its post-translational modification polysialic acid (polySia) are broadly implicated in neural development. Mice lacking the polysialyltransferases ST8SiaII and ST8SiaIV are devoid of polySia, and show severe malformation of major brain axon tracts. Here, we demonstrate how allelic variation of three interacting gene products (NCAM, ST8SiaII and ST8SiaIV) translates into various degrees of anterior commissure, corpus callosum and internal capsule hypoplasia. Loss of ST8SiaII alone caused mild, but distinct defects and the severity of the pathological phenotype found in mice lacking both polysialyltransferases could be stepwise attenuated by reducing NCAM expression. Analysis of mice with overall nine selected combinations of mutant NCAM and polysialyltransferase alleles revealed that the extent of the fibre tract deficiencies was not linked to the total amount of polySia or NCAM, but correlated strictly with the level of NCAM erroneously devoid of polySia during brain development. The defects implemented by the gain of polySia-free NCAM were reminiscent to abnormalities found in patients with schizophrenia. Since variations in <I>NCAM1</I> and <I>ST8SIA2</I> have been implicated in schizophrenia, these findings provide a mechanism how genetic interference with the complex coordination of NCAM polysialylation may lead to a neurodevelopmental predisposition to schizophrenia.</p>
]]></description>
<dc:creator><![CDATA[Hildebrandt, H., Muhlenhoff, M., Oltmann-Norden, I., Rockle, I., Burkhardt, H., Weinhold, B., Gerardy-Schahn, R.]]></dc:creator>
<dc:date>2009-05-14</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp117</dc:identifier>
<dc:title><![CDATA[Imbalance of neural cell adhesion molecule and polysialyltransferase alleles causes defective brain connectivity]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-14</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp105v1?rss=1">
<title><![CDATA[Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp105v1?rss=1</link>
<description><![CDATA[
<p><b>Brain atrophy measured by magnetic resonance structural imaging has been proposed as a surrogate marker for the early diagnosis of Alzheimer</b>'<b>s disease. Studies on large samples are still required to determine its practical interest at the individual level, especially with regards to the capacity of anatomical magnetic resonance imaging to disentangle the confounding role of the cognitive reserve in the early diagnosis of Alzheimer</b>'<b>s disease. One hundred and thirty healthy controls, 122 subjects with mild cognitive impairment of the amnestic type and 130 Alzheimer</b>'<b>s disease patients were included from the ADNI database and followed up for 24 months. After 24 months, 72 amnestic mild cognitive impairment had converted to Alzheimer</b>'<b>s disease (referred to as progressive mild cognitive impairment, as opposed to stable mild cognitive impairment). For each subject, cortical thickness was measured on the baseline magnetic resonance imaging volume. The resulting cortical thickness map was parcellated into 22 regions and a normalized thickness index was computed using the subset of regions (right medial temporal, left lateral temporal, right posterior cingulate) that optimally distinguished stable mild cognitive impairment from progressive mild cognitive impairment. We tested the ability of baseline normalized thickness index to predict evolution from amnestic mild cognitive impairment to Alzheimer</b>'<b>s disease and compared it to the predictive values of the main cognitive scores at baseline. In addition, we studied the relationship between the normalized thickness index, the education level and the timeline of conversion to Alzheimer</b>'<b>s disease. Normalized thickness index at baseline differed significantly among all the four diagnosis groups (<I>P</I> &lt; 0.001) and correctly distinguished Alzheimer</b>'<b>s disease patients from healthy controls with an 85% cross-validated accuracy. Normalized thickness index also correctly predicted evolution to Alzheimer</b>'<b>s disease for 76% of amnestic mild cognitive impairment subjects after cross-validation, thus showing an advantage over cognitive scores (range 63&ndash;72%). Moreover, progressive mild cognitive impairment subjects, who converted later than 1 year after baseline, showed a significantly higher education level than those who converted earlier than 1 year after baseline. Using a normalized thickness index-based criterion may help with early diagnosis of Alzheimer</b>'<b>s disease at the individual level, especially for highly educated subjects, up to 24 months before clinical criteria for Alzheimer</b>'<b>s disease diagnosis are met.</b></p>
]]></description>
<dc:creator><![CDATA[Querbes, O., Aubry, F., Pariente, J., Lotterie, J.-A., Demonet, J.-F., Duret, V., Puel, M., Berry, I., Fort, J.-C., Celsis, P., The Alzheimer's Disease Neuroimaging Initiative]]></dc:creator>
<dc:date>2009-05-12</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp105</dc:identifier>
<dc:title><![CDATA[Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-12</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp089v1?rss=1">
<title><![CDATA[Impaired small-world efficiency in structural cortical networks in multiple sclerosis associated with white matter lesion load]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp089v1?rss=1</link>
<description><![CDATA[
<p>White matter tracts, which play a crucial role in the coordination of information flow between different regions of grey matter, are particularly vulnerable to multiple sclerosis. Many studies have shown that the white matter lesions in multiple sclerosis are associated with focal abnormalities of grey matter, but little is known about the alterations in the coordinated patterns of cortical morphology among regions in the disease. Here, we used cortical thickness measurements from structural magnetic resonance imaging to investigate the relationship between the white matter lesion load and the topological efficiency of structural cortical networks in multiple sclerosis. Network efficiency was defined using a &lsquo;small-world&rsquo; network model that quantifies the effectiveness of information transfer within brain networks. In this study, we first classified patients (<I>n</I> = 330) into six subgroups according to their total white matter lesion loads, and identified structural brain networks for each multiple sclerosis group by thresholding the corresponding inter-regional cortical thickness correlation matrix, followed by a network efficiency analysis with graph theoretical approaches. The structural cortical networks in multiple sclerosis demonstrated efficient small-world architecture regardless of the lesion load, an organization that maximizes the information processing at a relatively low wiring cost. However, we found that the overall small-world network efficiency in multiple sclerosis was significantly disrupted in a manner proportional to the extent of total white matter lesions. Moreover, regional efficiency was also significantly decreased in specific brain regions, including the insula and precentral gyrus as well as regions of prefrontal and temporal association cortices. Finally, we showed that the lesions also altered many cortical thickness correlations in the frontal, temporal and parietal lobes. Our results suggest that the white matter lesions in multiple sclerosis might be associated with aberrant neuronal connectivity among widely distributed brain regions, and provide structural (morphological) evidence for the notion of multiple sclerosis as a disconnection syndrome.</p>
]]></description>
<dc:creator><![CDATA[He, Y., Dagher, A., Chen, Z., Charil, A., Zijdenbos, A., Worsley, K., Evans, A.]]></dc:creator>
<dc:date>2009-05-12</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp089</dc:identifier>
<dc:title><![CDATA[Impaired small-world efficiency in structural cortical networks in multiple sclerosis associated with white matter lesion load]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-12</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp071v1?rss=1">
<title><![CDATA[White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp071v1?rss=1</link>
<description><![CDATA[
<p>Frontotemporal dementia (FTD) and Alzheimer's disease are sometimes difficult to differentiate clinically because of overlapping symptoms. Using diffusion tensor imaging (DTI) measurements of fractional anisotropy (FA) can be useful in distinguishing the different patterns of white matter degradation between the two dementias. In this study, we performed MRI scans in a 4 Tesla MRI machine including T<SUB>1</SUB>-weighted structural images and diffusion tensor images in 18 patients with FTD, 18 patients with Alzheimer's disease and 19 cognitively normal (CN) controls. FA was measured selectively in specific fibre tracts (including corpus callosum, cingulum, uncinate and corticospinal tracts) as well as globally in a voxel-by-voxel analysis. Patients with FTD were associated with reductions of FA in frontal and temporal regions including the anterior corpus callosum (<I>P</I> &lt; 0.001), bilateral anterior (left <I>P</I> &lt; 0.001; right <I>P</I> = 0.005), descending (left <I>P</I> &lt; 0.001; right <I>P</I> = 0.003) cingulum tracts, and uncinate tracts (left <I>P</I> &lt; 0.001; right <I>P</I> = 0.005), compared to controls. Patients with Alzheimer's disease were associated with reductions of FA in parietal, temporal and frontal regions including the left anterior (<I>P</I> = 0.003) and posterior (<I>P</I> = 0.002) cingulum tracts, bilateral descending cingulum tracts (<I>P</I> &lt; 0.001) and left uncinate tracts (<I>P</I> &lt; 0.001) compared to controls. When compared with Alzheimer's disease, FTD was associated with greater reductions of FA in frontal brain regions, whereas no region in Alzheimer's disease showed greater reductions of FA when compared to FTD. In conclusion, the regional patterns of anisotropy reduction in FTD and Alzheimer's disease compared to controls suggest a characteristic distribution of white matter degradation in each disease. Moreover, the white matter degradation seems to be more prominent in FTD than in Alzheimer's disease. Taken together, the results suggest that white matter degradation measured with DTI may improve the diagnostic differentiation between FTD and Alzheimer's disease.</p>
]]></description>
<dc:creator><![CDATA[Zhang, Y., Schuff, N., Du, A.-T., Rosen, H. J., Kramer, J. H., Gorno-Tempini, M. L., Miller, B. L., Weiner, M. W.]]></dc:creator>
<dc:date>2009-05-12</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp071</dc:identifier>
<dc:title><![CDATA[White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-12</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp111v1?rss=1">
<title><![CDATA[Causal role of prefrontal cortex in the threshold for access to consciousness]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp111v1?rss=1</link>
<description><![CDATA[
<p>What neural mechanisms support our conscious perception of briefly presented stimuli? Some theories of conscious access postulate a key role of top&ndash;down amplification loops involving prefrontal cortex (PFC). To test this issue, we measured the visual backward masking threshold in patients with focal prefrontal lesions, using both objective and subjective measures while controlling for putative attention deficits. In all conditions of temporal or spatial attention cueing, the threshold for access to consciousness was systematically shifted in patients, particular after a lesion of the left anterior PFC. The deficit affected subjective reports more than objective performance, and objective performance conditioned on subjective visibility was essentially normal. We conclude that PFC makes a causal contribution to conscious visual perception of masked stimuli, and outline a dual-route signal detection theory of objective and subjective decision making.</p>
]]></description>
<dc:creator><![CDATA[Del Cul, A., Dehaene, S., Reyes, P., Bravo, E., Slachevsky, A.]]></dc:creator>
<dc:date>2009-05-11</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp111</dc:identifier>
<dc:title><![CDATA[Causal role of prefrontal cortex in the threshold for access to consciousness]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-11</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp053v1?rss=1">
<title><![CDATA[Gait freezing in Parkinson's disease and the stride length sequence effect interaction]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp053v1?rss=1</link>
<description><![CDATA[
<p>Freezing of gait (FOG) has been identified as one of the main contributors to gait disturbances in Parkinson's disease. While the pathophysiology remains enigmatic, several factors such as step length and the sequence effect (step to step reduction in amplitude) may lead to the occurrence of FOG. It was hypothesized that by reducing step length, FOG episodes would present more frequently if a significant sequence effect (measured as a regression slope) was co-existent in the subject. Twenty-six participants with Parkinson's disease were separated clinically into a freezing (PD + FOG, <I>n</I> = 16) and non-freezing (PD &ndash; FOG, <I>n</I> = 10) group, with 10 age-matched control participants. Testing involved walking trials where preferred step length was set at 100%, 75%, 50% and 25% of normalized step length. The number of FOG episodes increased in the 50% condition and further increased in the 25% condition compared to other conditions. The participants with FOG also demonstrated a larger average regression slope, with significant differences in the 75%, 50% and 25% conditions when compared to the PD &ndash; FOG and control groups. There were no significant differences when comparing the slope of the PD &ndash; FOG and control group, indicating the reduced step length and the sequence effect may have led to the occurrence of FOG. These findings support the possible dual requirement of a reduced step length and a successive step to step amplitude reduction to lead to FOG.</p>
]]></description>
<dc:creator><![CDATA[Chee, R., Murphy, A., Danoudis, M., Georgiou-Karistianis, N., Iansek, R.]]></dc:creator>
<dc:date>2009-05-11</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp053</dc:identifier>
<dc:title><![CDATA[Gait freezing in Parkinson's disease and the stride length sequence effect interaction]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-11</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp098v1?rss=1">
<title><![CDATA[Functional integration between the posterior hippocampus and prefrontal cortex is impaired in both first episode schizophrenia and the at risk mental state]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp098v1?rss=1</link>
<description><![CDATA[
<p>Recent neuroimaging studies have reported deficits in functional integration between prefrontal cortex and the hippocampal formation in schizophrenia. It is unclear whether these alterations are a consequence of chronic illness or its treatment, and whether they are also evident in non-psychotic subjects at increased risk of the disorder. We addressed these issues by investigating prefrontal&ndash;hippocampal interactions in patients with first episode schizophrenia and subjects with an At Risk Mental State (ARMS). Using functional Magnetic Resonance Imaging, we measured brain responses from 16 individuals with an ARMS, 10 patients with first episode schizophrenia and 14 healthy controls during a delayed matching to sample task. Dynamic causal modelling was used to estimate the effective connectivity between prefrontal cortex and anterior and posterior hippocampal regions. The normal pattern of effective connectivity from the right posterior hippocampus to the right inferior frontal gyrus was significantly decreased in both first episode patients and subjects with an ARMS (ANOVA; <I>F</I> = 8.16, <I>P</I> = 0.01). Interactions between the inferior frontal gyrus and the anterior part of the hippocampus did not differ across the three groups. Perturbed hippocampal&ndash;prefrontal interactions are evident in individuals at high risk of developing psychosis and in patients who have just developed schizophrenia. This suggests that it may be a correlate of increased vulnerability to psychosis and that it is not attributable to an effect of chronic illness or its treatment.</p>
]]></description>
<dc:creator><![CDATA[Benetti, S., Mechelli, A., Picchioni, M., Broome, M., Williams, S., McGuire, P.]]></dc:creator>
<dc:date>2009-05-06</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp098</dc:identifier>
<dc:title><![CDATA[Functional integration between the posterior hippocampus and prefrontal cortex is impaired in both first episode schizophrenia and the at risk mental state]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-06</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp095v1?rss=1">
<title><![CDATA[Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp095v1?rss=1</link>
<description><![CDATA[
<p>Affective disorders are frequent and disabling conditions in multiple sclerosis; however, the underlying neurobiological mechanisms are still poorly understood and investigated. Previous structural imaging studies have suggested that damage of frontal and temporal cortices plays an important role in the genesis of emotional disorders in multiple sclerosis, although psychosocial factors have been also implicated. However, this initial research may not have fully characterized the brain's functional dynamics of emotional processes in multiple sclerosis. Functional magnetic resonance imaging (fMRI) appears, therefore, to be a sensible tool to explore neurobiological mechanisms of emotions in multiple sclerosis since it also allows investigation of the functional connectivity or &lsquo;communication&rsquo; between critical regions in affective behaviour [e.g. the prefrontal cortex (PFC) and amygdala]. In the present study, functional imaging was used to investigate the neural substrate of processing emotions in 12 multiple sclerosis patients relative to 12 healthy subjects matched for age and educational level. Only relapsing-remitting multiple sclerosis patients, who were cognitively unimpaired and who did not assume disease-modifying therapies, were included, given the potential confounding effect of these variables in the genesis of emotional symptoms. Brain responses were recorded in all participants while they executed an active task that consisted of processing emotional relative to neutral stimuli. Structural measures (i.e. total lesion load, grey matter, white matter and total brain volume) were also recorded to control for any effect of these variables. Despite similar performances during the task, and no differences in structural measures, multiple sclerosis patients displayed significantly greater responses within the ventrolateral PFC [<I>t</I>'s &gt; 5, <I>P</I>'s &lt; 0.02, Family Wise Error (FWE), small volume correction (svc)], compared to controls. Multiple sclerosis patients also showed a lack of functional connectivity between two prefrontal areas and the amygdala, a subcortical region critically involved in the generation of negative feelings (<I>t</I>'s &gt; 4, <I>P</I>'s &lt; 0.05, FWE, svc). It is likely that pathological changes related to the disease are reflected in an abnormal &lsquo;communication&rsquo; between key emotional regions and that adaptive processes take place and become evident as enhanced responses of task-specific areas (i.e. the ventrolateral PFC). Local reorganizations in the brain can be viewed as compensatory mechanisms aimed to limit the clinical expression of emotional symptoms in multiple sclerosis. Overall our findings offer new insights into the neurobiological mechanisms of emotions in multiple sclerosis and provide evidence that they resemble those described for some psychiatric disorders.</p>
]]></description>
<dc:creator><![CDATA[Passamonti, L., Cerasa, A., Liguori, M., Gioia, M. C., Valentino, P., Nistico, R., Quattrone, A., Fera, F.]]></dc:creator>
<dc:date>2009-05-06</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp095</dc:identifier>
<dc:title><![CDATA[Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-06</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp094v1?rss=1">
<title><![CDATA[Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp094v1?rss=1</link>
<description><![CDATA[
<p>Parkinson's disease is characterized by the degeneration of dopaminergic pathways projecting to the striatum. These pathways are implicated in reward prediction. In this study, we investigated reward and punishment processing in young, never-medicated Parkinson's disease patients, recently medicated patients receiving the dopamine receptor agonists pramipexole and ropinirole and healthy controls. The never-medicated patients were also re-evaluated after 12 weeks of treatment with dopamine agonists. Reward and punishment processing was assessed by a feedback-based probabilistic classification task. Personality characteristics were measured by the temperament and character inventory. Results revealed that never-medicated patients with Parkinson's disease showed selective deficits on reward processing and novelty seeking, which were remediated by dopamine agonists. These medications disrupted punishment processing. In addition, dopamine agonists increased the correlation between reward processing and novelty seeking, whereas these drugs decreased the correlation between punishment processing and harm avoidance. Our finding that dopamine agonist administration in young patients with Parkinson's disease resulted in increased novelty seeking, enhanced reward processing, and decreased punishment processing may shed light on the cognitive and personality bases of the impulse control disorders, which arise as side-effects of dopamine agonist therapy in some Parkinson's disease patients.</p>
]]></description>
<dc:creator><![CDATA[Bodi, N., Keri, S., Nagy, H., Moustafa, A., Myers, C. E., Daw, N., Dibo, G., Takats, A., Bereczki, D., Gluck, M. A.]]></dc:creator>
<dc:date>2009-05-04</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp094</dc:identifier>
<dc:title><![CDATA[Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-04</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp091v1?rss=1">
<title><![CDATA[Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp091v1?rss=1</link>
<description><![CDATA[
<p>A challenge in developing informative neuroimaging biomarkers for early diagnosis of Alzheimer's disease is the need to identify biomarkers that are evident before the onset of clinical symptoms, and which have sufficient sensitivity and specificity on an individual patient basis. Recent literature suggests that spatial patterns of brain atrophy discriminate amongst Alzheimer's disease, mild cognitive impairment (MCI) and cognitively normal (CN) older adults with high accuracy on an individual basis, thereby offering promise that subtle brain changes can be detected during prodromal Alzheimer's disease stages. Here, we investigate whether these spatial patterns of brain atrophy can be detected in CN and MCI individuals and whether they are associated with cognitive decline. Images from the Alzheimer's Disease Neuroimaging Initiative (ADNI) were used to construct a pattern classifier that recognizes spatial patterns of brain atrophy which best distinguish Alzheimer's disease patients from CN on an individual person basis. This classifier was subsequently applied to longitudinal magnetic resonance imaging scans of CN and MCI participants in the Baltimore Longitudinal Study of Aging (BLSA) neuroimaging study. The degree to which Alzheimer's disease-like patterns were present in CN and MCI subjects was evaluated longitudinally in relation to cognitive performance. The oldest BLSA CN individuals showed progressively increasing Alzheimer's disease-like patterns of atrophy, and individuals with these patterns had reduced cognitive performance. MCI was associated with steeper longitudinal increases of Alzheimer's disease-like patterns of atrophy, which separated them from CN (receiver operating characteristic area under the curve equal to 0.89). Our results suggest that imaging-based spatial patterns of brain atrophy of Alzheimer's disease, evaluated with sophisticated pattern analysis and recognition methods, may be useful in discriminating among CN individuals who are likely to be stable versus those who will show cognitive decline. Future prospective studies will elucidate the temporal dynamics of spatial atrophy patterns and the emergence of clinical symptoms.</p>
]]></description>
<dc:creator><![CDATA[Davatzikos, C., Xu, F., An, Y., Fan, Y., Resnick, S. M]]></dc:creator>
<dc:date>2009-05-04</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp091</dc:identifier>
<dc:title><![CDATA[Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-04</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp086v1?rss=1">
<title><![CDATA[Impaired consciousness during temporal lobe seizures is related to increased long-distance cortical-subcortical synchronization]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp086v1?rss=1</link>
<description><![CDATA[
<p>Loss of consciousness (LOC) is a dramatic clinical manifestation of temporal lobe seizures. Its underlying mechanism could involve altered coordinated neuronal activity between the brain regions that support conscious information processing. The consciousness access hypothesis assumes the existence of a global workspace in which information becomes available via synchronized activity within neuronal modules, often widely distributed throughout the brain. Re-entry loops and, in particular, thalamo-cortical communication would be crucial to functionally bind different modules together. In the present investigation, we used intracranial recordings of cortical and subcortical structures in 12 patients, with intractable temporal lobe epilepsy (TLE), as part of their presurgical evaluation to investigate the relationship between states of consciousness and neuronal activity within the brain. The synchronization of electroencephalography signals between distant regions was estimated as a function of time by using non-linear regression analysis. We report that LOC occurring during temporal lobe seizures is characterized by increased long-distance synchronization between structures that are critical in processing awareness, including thalamus (Th) and parietal cortices. The degree of LOC was found to correlate with the amount of synchronization in thalamo-cortical systems. We suggest that excessive synchronization overloads the structures involved in consciousness processing, preventing them from treating incoming information, thus resulting in LOC.</p>
]]></description>
<dc:creator><![CDATA[Arthuis, M., Valton, L., Regis, J., Chauvel, P., Wendling, F., Naccache, L., Bernard, C., Bartolomei, F.]]></dc:creator>
<dc:date>2009-05-04</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp086</dc:identifier>
<dc:title><![CDATA[Impaired consciousness during temporal lobe seizures is related to increased long-distance cortical-subcortical synchronization]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-04</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp077v1?rss=1">
<title><![CDATA[Combined magnetic resonance imaging and positron emission tomography brain imaging in behavioural variant frontotemporal degeneration: refining the clinical phenotype]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp077v1?rss=1</link>
<description><![CDATA[
<p>In patients with the behavioural variant of frontotemporal dementia, prognosis is often surprisingly good when there is normal structural imaging at presentation. Imaging abnormalities are not, however, mandatory for diagnosis, which in the absence of suitable biomarkers, remains entirely clinical. We aimed to test whether cases with normal structural imaging have hypometabolism suggestive of underlying neurodegeneration, or whether it is likely that such patients are false positive diagnoses of behavioural variant frontotemporal dementia. Patients with this disease (<I>n</I> = 24) and age-matched controls (<I>n</I> = 12) underwent both magnetic resonance imaging (MRI) and quantitative fluorodeoxyglucose-positron emission tomography (FDG-PET) scanning, together with clinical and behavioural assessments. Regions of interest were used to calculate metabolic rate in frontotemporal and control regions. Using a semi-quantitative visual rating scale, patients were divided into MRI-abnormal (<I>n</I> = 15) and MRI-normal groups (<I>n</I> = 9). There was definite frontotemporal hypometabolism in the MRI-abnormal group (particularly in the mesial and orbitofrontal regions) even after accounting for brain volume loss, whereas the MRI-normal group was similar to controls in all regions. In contrast, cognitive and behavioural indices did not separate the two behavioural variant frontotemporal dementia patient groups. The results suggest that the clinical syndrome of the behavioural variant of frontotemporal dementia may not be specific for a neurodegenerative disease, and we hypothesize the existence of a phenocopy. A number of alternative neuropsychiatric and developmental explanations are discussed. We advise caution in diagnosing the illness in patients without imaging abnormalities, and propose that imaging findings are included in criteria for diagnosis.</p>
]]></description>
<dc:creator><![CDATA[Kipps, C. M., Hodges, J. R., Fryer, T. D., Nestor, P. J.]]></dc:creator>
<dc:date>2009-05-04</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp077</dc:identifier>
<dc:title><![CDATA[Combined magnetic resonance imaging and positron emission tomography brain imaging in behavioural variant frontotemporal degeneration: refining the clinical phenotype]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-05-04</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp088v1?rss=1">
<title><![CDATA[Decreased connectivity and cerebellar activity in autism during motor task performance]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp088v1?rss=1</link>
<description><![CDATA[
<p>Although motor deficits are common in autism, the neural correlates underlying the disruption of even basic motor execution are unknown. Motor deficits may be some of the earliest identifiable signs of abnormal development and increased understanding of their neural underpinnings may provide insight into autism-associated differences in parallel systems critical for control of more complex behaviour necessary for social and communicative development. Functional magnetic resonance imaging was used to examine neural activation and connectivity during sequential, appositional finger tapping in 13 children, ages 8&ndash;12 years, with high-functioning autism (HFA) and 13 typically developing (TD), age- and sex-matched peers. Both groups showed expected primary activations in cortical and subcortical regions associated with motor execution [contralateral primary sensorimotor cortex, contralateral thalamus, ipsilateral cerebellum, supplementary motor area (SMA)]; however, the TD group showed greater activation in the ipsilateral anterior cerebellum, while the HFA group showed greater activation in the SMA. Although activation differences were limited to a subset of regions, children with HFA demonstrated diffusely decreased connectivity across the motor execution network relative to control children. The between-group dissociation of cerebral and cerebellar motor activation represents the first neuroimaging data of motor dysfunction in children with autism, providing insight into potentially abnormal circuits impacting development. Decreased cerebellar activation in the HFA group may reflect difficulty shifting motor execution from cortical regions associated with effortful control to regions associated with habitual execution. Additionally, diffusely decreased connectivity may reflect poor coordination within the circuit necessary for automating patterned motor behaviour. The findings might explain impairments in motor development in autism, as well as abnormal and delayed acquisition of gestures important for socialization and communication.</p>
]]></description>
<dc:creator><![CDATA[Mostofsky, S. H., Powell, S. K., Simmonds, D. J., Goldberg, M. C., Caffo, B., Pekar, J. J.]]></dc:creator>
<dc:date>2009-04-23</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp088</dc:identifier>
<dc:title><![CDATA[Decreased connectivity and cerebellar activity in autism during motor task performance]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-23</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp083v1?rss=1">
<title><![CDATA[Brain regions underlying word finding difficulties in temporal lobe epilepsy]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp083v1?rss=1</link>
<description><![CDATA[
<p>Word finding difficulties are often reported by epileptic patients with seizures originating from the language dominant cerebral hemisphere, for example, in temporal lobe epilepsy. Evidence regarding the brain regions underlying this deficit comes from studies of peri-operative electro-cortical stimulation, as well as post-surgical performance. This evidence has highlighted a role for the anterior part of the dominant temporal lobe in oral word production. These conclusions contrast with findings from activation studies involving healthy speakers or acute ischaemic stroke patients, where the region most directly related to word retrieval appears to be the posterior part of the left temporal lobe. To clarify the neural basis of word retrieval in temporal lobe epilepsy, we tested forty-three drug-resistant temporal lobe epilepsy patients (28 left, 15 right). Comprehensive neuropsychological and language assessments were performed. Single spoken word production was elicited with picture or definition stimuli. Detailed analysis allowed the distinction of impaired word retrieval from other possible causes of naming failure. Finally, the neural substrate of the deficit was assessed by correlating word retrieval performance and resting-state brain metabolism in 18 fluoro-2-deoxy-<scp>d</scp>-glucose-Positron Emission Tomography. Naming difficulties often resulted from genuine word retrieval failures (anomic states), both in picture and in definition tasks. Left temporal lobe epilepsy patients showed considerably worse performance than right temporal lobe epilepsy patients. Performance was poorer in the definition than in the picture task. Across patients and the left temporal lobe epilepsy subgroup, frequency of anomic state was negatively correlated with resting-state brain metabolism in left posterior and basal temporal regions (Brodmann's area 20-37-39). These results show the involvement of posterior temporal regions, within a larger antero-posterior-basal temporal network, in the specific process of word retrieval in temporal lobe epilepsy. A tentative explanation for these findings is that epilepsy induces functional deafferentation between anterior temporal structures devoted to semantic processing and neocortical posterior temporal structures devoted to lexical processing.</p>
]]></description>
<dc:creator><![CDATA[Fonseca, A. T.-D., Guedj, E., Alario, F-X., Laguitton, V., Mundler, O., Chauvel, P., Liegeois-Chauvel, C.]]></dc:creator>
<dc:date>2009-04-21</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp083</dc:identifier>
<dc:title><![CDATA[Brain regions underlying word finding difficulties in temporal lobe epilepsy]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-21</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp060v2?rss=1">
<title><![CDATA[In the psychiatrist's chair: how neurologists understand conversion disorder]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp060v2?rss=1</link>
<description><![CDATA[
<p>Conversion disorder (&lsquo;hysteria&rsquo;) was largely considered to be a neurological problem in the 19th century, but without a neuropathological explanation it was commonly assimilated with malingering. The theories of Janet and Freud transformed hysteria into a psychiatric condition, but as such models decline in popularity and a neurobiology of conversion has yet to be found, today's neurologists once again face a disorder without an accepted model. This article explores how today's neurologists understand conversion through in-depth interviews with 22 neurology consultants. The neurologists endorsed psychological models but did not understand their patients in such terms. Rather, they distinguished conversion from other unexplained conditions clinically by its severity and inconsistency. While many did not see this as clearly distinct from feigning, they did not feel that this was their problem to resolve. They saw themselves as &lsquo;agnostic&rsquo; regarding non-neuropathological explanations. However, since neurologists are in some ways more expert in conversion than psychiatrists, their continuing support for the deception model is important, and begs an explanation. One reason for the model's persistence may be that it is employed as a diagnostic device, used to differentiate between those unexplained symptoms that could, in principle, have a medical explanation and those that could not.</p>
]]></description>
<dc:creator><![CDATA[Kanaan, R., Armstrong, D., Barnes, P., Wessely, S.]]></dc:creator>
<dc:date>2009-04-16</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp060</dc:identifier>
<dc:title><![CDATA[In the psychiatrist's chair: how neurologists understand conversion disorder]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-16</prism:publicationDate>
<prism:section>Occasional Paper</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp079v1?rss=1">
<title><![CDATA[Resonance in subthalamo-cortical circuits in Parkinson's disease]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp079v1?rss=1</link>
<description><![CDATA[
<p>Neuronal activity within and across the cortex and basal ganglia is pathologically synchronized, particularly at ~ 20 Hz in patients with Parkinson's disease. Defining how activities in spatially distributed brain regions overtly synchronize in narrow frequency bands is critical for understanding disease processes like Parkinson's disease. To address this, we studied cortical responses to electrical stimulation of the subthalamic nucleus (STN) at various frequencies between 5 and 30 Hz in two cohorts of eight patients with Parkinson's disease from two different surgical centres. We found that evoked activity consisted of a series of diminishing waves with a peak latency of 21 ms for the first wave in the series. The cortical evoked potentials (cEPs) averaged in each group were well fitted by a damped oscillator function (<I>r</I> &ge;0.9, <I>P</I> &lt; 0.00001). Fits suggested that the natural frequency of the subthalamo-cortical circuit was around 20 Hz. When the system was forced at this frequency by stimulation of the STN at 20 Hz, the undamped amplitude of the modelled cortical response increased relative to that with 5 Hz stimulation in both groups (<I>P</I> &le; 0.005), consistent with resonance. Restoration of dopaminergic input by treatment with levodopa increased the damping of oscillatory activity (as measured by the modelled damping factor) in both patient groups (<I>P</I> &le;0.001). The increased damping would tend to limit resonance, as confirmed in simulations. Our results show that the basal ganglia&ndash;cortical network involving the STN has a tendency to resonate at ~ 20 Hz in Parkinsonian patients. This resonance phenomenon may underlie the propagation and amplification of activities synchronized around this frequency. Crucially, dopamine acts to increase damping and thereby limit resonance in this basal ganglia&ndash;cortical network.</p>
]]></description>
<dc:creator><![CDATA[Eusebio, A., Pogosyan, A., Wang, S., Averbeck, B., Gaynor, L. D., Cantiniaux, S., Witjas, T., Limousin, P., Azulay, J.-P., Brown, P.]]></dc:creator>
<dc:date>2009-04-15</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp079</dc:identifier>
<dc:title><![CDATA[Resonance in subthalamo-cortical circuits in Parkinson's disease]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-15</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp027v1?rss=1">
<title><![CDATA[Clinical use of ictal SPECT in secondarily generalized tonic-clonic seizures]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp027v1?rss=1</link>
<description><![CDATA[
<p>Partial seizures produce increased cerebral blood flow in the region of seizure onset. These regional cerebral blood flow increases can be detected by single photon emission computed tomography (ictal SPECT), providing a useful clinical tool for seizure localization. However, when partial seizures secondarily generalize, there are often questions of interpretation since propagation of seizures could produce ambiguous results. Ictal SPECT from secondarily generalized seizures has not been thoroughly investigated. We analysed ictal SPECT from 59 secondarily generalized tonic&ndash;clonic seizures obtained during epilepsy surgery evaluation in 53 patients. Ictal versus baseline interictal SPECT difference analysis was performed using ISAS (<inter-ref locator="http://spect.yale.edu" locator-type="url">http://spect.yale.edu</inter-ref>). SPECT injection times were classified based on video/EEG review as either pre-generalization, during generalization or in the immediate post-ictal period. We found that in the pre-generalization and generalization phases, ictal SPECT showed significantly more regions of cerebral blood flow increases than in partial seizures without secondary generalization. This made identification of a single unambiguous region of seizure onset impossible 50% of the time with ictal SPECT in secondarily generalized seizures. However, cerebral blood flow increases on ictal SPECT correctly identified the hemisphere (left versus right) of seizure onset in 84% of cases. In addition, when a single unambiguous region of cerebral blood flow increase was seen on ictal SPECT, this was the correct localization 80% of the time. In agreement with findings from partial seizures without secondary generalization, cerebral blood flow increases in the post-ictal period and cerebral blood flow decreases during or following seizures were not useful for localizing seizure onset. Interestingly, however, cerebral blood flow hypoperfusion during the generalization phase (but not pre-generalization) was greater on the side <I>opposite</I> to seizure onset in 90% of patients. These findings suggest that, with appropriate cautious interpretation, ictal SPECT in secondarily generalized seizures can help localize the region of seizure onset.</p>
]]></description>
<dc:creator><![CDATA[Varghese, G. I., Purcaro, M. J., Motelow, J. E., Enev, M., McNally, K. A., Levin, A. R., Hirsch, L. J., Tikofsky, R., Paige, A. L., Zubal, I. G., Spencer, S. S., Blumenfeld, H.]]></dc:creator>
<dc:date>2009-04-01</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp027</dc:identifier>
<dc:title><![CDATA[Clinical use of ictal SPECT in secondarily generalized tonic-clonic seizures]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp040v1?rss=1">
<title><![CDATA[Language production in the non-dominant hemisphere as a potential source of auditory verbal hallucinations]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp040v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Sommer, I. E., Diederen, K. M.]]></dc:creator>
<dc:date>2009-03-31</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp040</dc:identifier>
<dc:title><![CDATA[Language production in the non-dominant hemisphere as a potential source of auditory verbal hallucinations]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-03-31</prism:publicationDate>
<prism:section>Letter To The Editor</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp038v1?rss=1">
<title><![CDATA[Disembodied hallucinatory voices: Comment on Sommer et al., 2008 Brain 131, 3169-77]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp038v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Craig, A. D.]]></dc:creator>
<dc:date>2009-03-31</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp038</dc:identifier>
<dc:title><![CDATA[Disembodied hallucinatory voices: Comment on Sommer et al., 2008 Brain 131, 3169-77]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-03-31</prism:publicationDate>
<prism:section>Letter To The Editor</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp064v1?rss=1">
<title><![CDATA[Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp064v1?rss=1</link>
<description><![CDATA[
<p>Human prion diseases present substantial scientific and public health challenges. They are unique in being sporadic, infectious and inherited, and their pathogen is distinct from all other pathogens in lacking nucleic acids. Despite progress in understanding the molecular structure of prions, their initial cerebral pathophysiology and the loci of cerebral injury are poorly understood. As part of a large prospective study, we analysed early diffusion MRI scans of 14 patients with the E200K genetic form of Creutzfeldt&ndash;Jakob Disease, 20 healthy carriers of this mutation that causes the disease and 20 controls without the mutation from the same families. Cerebral diffusion was quantified by the Apparent Diffusion Coefficient, and analysed by voxel-wise statistical parametric mapping technique. Compared to the mutation-negative controls, diffusion was significantly reduced in a thalamic-striatal network, comprising the putamen and mediodorsal, ventrolateral and pulvinar thalamic nuclei, in both the patients and the healthy mutation carriers. With disease onset, these diffusion reductions intensified, but did not spread to other areas. The caudate nucleus was reduced only after symptomatic onset. These findings indicate that cerebral diffusion reductions can be detected early in the course of Creutzfeldt&ndash;Jakob Disease, and years before symptomatic onset in mutation carriers, in a distinct subcortical network. We suggest that this network is centrally involved in the pathogenesis of Creutzfeldt&ndash;Jakob Disease, and its anatomical connections are sufficient to account for the common symptoms of this disease. Further, we suggest that the abnormalities in healthy mutation-carrying subjects may reflect the accumulation of abnormal prion protein and/or associated vacuolation at this time, temporally close to disease onset.</p>
]]></description>
<dc:creator><![CDATA[Lee, H., Rosenmann, H., Chapman, J., Kingsley, P. B., Hoffmann, C., Cohen, O. S., Kahana, E., Korczyn, A. D., Prohovnik, I.]]></dc:creator>
<dc:date>2009-03-24</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp064</dc:identifier>
<dc:title><![CDATA[Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-03-24</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp022v1?rss=1">
<title><![CDATA[Response to letter from Bernardi]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp022v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Hicks, D., Lampe, A., Laval, S., Allamand, V., Jimenez-Mallebrera, C., Walter, M., Muntoni, F., Quijano-Roy, S., Richard, P., Straub, V., Lochmuller, H., Bushby, K.]]></dc:creator>
<dc:date>2009-03-17</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp022</dc:identifier>
<dc:title><![CDATA[Response to letter from Bernardi]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-03-17</prism:publicationDate>
<prism:section>Letter to the Editor</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp021v1?rss=1">
<title><![CDATA[On the pathogenesis of collagen VI muscular dystrophies--Comment on article of Hicks et al.]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp021v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Bernardi, P., Bonaldo, P., Maraldi, N. M., Merlini, L., Sabatelli, P.]]></dc:creator>
<dc:date>2009-03-17</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp021</dc:identifier>
<dc:title><![CDATA[On the pathogenesis of collagen VI muscular dystrophies--Comment on article of Hicks et al.]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-03-17</prism:publicationDate>
<prism:section>Letter to the Editor</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awp043v1?rss=1">
<title><![CDATA[Focal laser-lesions activate an endogenous population of neural stem/progenitor cells in the adult visual cortex]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awp043v1?rss=1</link>
<description><![CDATA[
<p>CNS lesions stimulate adult neurogenic niches. Endogenous neural stem/progenitor cells represent a potential resource for CNS regeneration. Here, we investigate the response to unilateral focal laser-lesions applied to the visual cortex of juvenile rats. Within 3 days post-lesion, an ipsilateral increase of actively cycling cells was observed in cortical layer one and in the callosal white matter within the lesion penumbra. The cells expressed the neural stem/progenitor cell marker Nestin and the 473HD-epitope. Tissue prepared from the lesion area by micro-dissection generated self-renewing, multipotent neurospheres, while cells from the contralateral visual cortex did not. The newly formed neural stem/progenitor cells in the lesion zone might support neurogenesis, as suggested by the expression of Pax6 and Doublecortin, a marker of newborn neurons. We propose that focal laser-lesions may induce the emergence of stem/progenitor cells with neurogenic potential. This could underlie the beneficial effects of laser application in neurosurgery.</p>
]]></description>
<dc:creator><![CDATA[Sirko, S., Neitz, A., Mittmann, T., Horvat-Brocker, A., Holst, A. v., Eysel, U. T., Faissner, A.]]></dc:creator>
<dc:date>2009-03-13</dc:date>
<dc:identifier>info:doi/10.1093/brain/awp043</dc:identifier>
<dc:title><![CDATA[Focal laser-lesions activate an endogenous population of neural stem/progenitor cells in the adult visual cortex]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2009-03-13</prism:publicationDate>
<prism:section>Original Articles</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awn181v1?rss=1">
<title><![CDATA[Corrigendum]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awn181v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-07-24</dc:date>
<dc:identifier>info:doi/10.1093/brain/awn181</dc:identifier>
<dc:title><![CDATA[Corrigendum]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-07-24</prism:publicationDate>
<prism:section>Corrigendum</prism:section>
</item>

<item rdf:about="http://brain.oxfordjournals.org/cgi/content/short/awh430v4?rss=1">
<title><![CDATA[Selective impairment of hand mental rotation in patients with focal hand dystonia]]></title>
<link>http://brain.oxfordjournals.org/cgi/content/short/awh430v4?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Fiorio, M., Tinazzi, M., Aglioti, S. M.]]></dc:creator>
<dc:date>2005-05-25</dc:date>
<dc:identifier>info:doi/10.1093/brain/awh430</dc:identifier>
<dc:title><![CDATA[Selective impairment of hand mental rotation in patients with focal hand dystonia]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2005-05-25</prism:publicationDate>
<prism:section>Retraction</prism:section>
</item>

</rdf:RDF>